Query 015819
Match_columns 399
No_of_seqs 225 out of 1944
Neff 10.4
Searched_HMMs 46136
Date Fri Mar 29 01:11:30 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/015819.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/015819hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0534 NorM Na+-driven multid 100.0 1E-50 2.3E-55 385.0 45.5 365 32-399 13-381 (455)
2 PRK10367 DNA-damage-inducible 100.0 1.1E-46 2.4E-51 357.5 46.0 353 32-387 5-360 (441)
3 PRK10189 MATE family multidrug 100.0 3.5E-46 7.6E-51 357.3 46.9 371 24-399 19-399 (478)
4 PRK00187 multidrug efflux prot 100.0 1.6E-45 3.4E-50 352.7 46.7 365 32-399 6-381 (464)
5 PRK09575 vmrA multidrug efflux 100.0 3.1E-45 6.7E-50 350.2 44.5 365 32-398 8-375 (453)
6 PRK01766 multidrug efflux prot 100.0 1E-43 2.3E-48 341.1 46.9 365 32-399 8-379 (456)
7 TIGR00797 matE putative efflux 100.0 2.6E-38 5.6E-43 293.0 43.4 338 44-384 1-341 (342)
8 KOG1347 Uncharacterized membra 100.0 9.1E-34 2E-38 267.1 38.1 366 32-399 24-389 (473)
9 TIGR01695 mviN integral membra 100.0 2.4E-29 5.2E-34 245.0 44.3 352 38-398 2-367 (502)
10 TIGR02900 spore_V_B stage V sp 100.0 2.5E-29 5.5E-34 244.1 39.1 351 39-397 2-370 (488)
11 PRK15099 O-antigen translocase 100.0 5.6E-28 1.2E-32 229.5 39.0 338 38-391 3-344 (416)
12 PF03023 MVIN: MviN-like prote 99.9 1.1E-21 2.3E-26 187.0 42.6 324 66-397 5-341 (451)
13 PRK00187 multidrug efflux prot 99.9 5.1E-23 1.1E-27 197.4 27.4 208 30-238 230-444 (464)
14 COG0728 MviN Uncharacterized m 99.9 1.8E-20 3.9E-25 175.9 43.0 359 34-397 5-375 (518)
15 COG0534 NorM Na+-driven multid 99.9 8.2E-23 1.8E-27 194.4 27.4 214 26-241 231-446 (455)
16 PRK10189 MATE family multidrug 99.9 3E-22 6.5E-27 192.3 28.5 211 31-242 254-466 (478)
17 PRK01766 multidrug efflux prot 99.9 3.6E-22 7.9E-27 191.9 26.9 206 32-238 235-442 (456)
18 PRK09575 vmrA multidrug efflux 99.9 9.8E-22 2.1E-26 188.2 27.6 208 28-238 226-436 (453)
19 PRK10459 colanic acid exporter 99.9 1.3E-19 2.9E-24 176.0 38.2 335 35-395 4-341 (492)
20 TIGR01695 mviN integral membra 99.9 7.2E-20 1.6E-24 178.5 30.3 206 31-238 218-428 (502)
21 COG2244 RfbX Membrane protein 99.9 1.8E-18 4E-23 167.6 33.5 343 33-395 3-348 (480)
22 PRK10367 DNA-damage-inducible 99.8 1.8E-18 3.9E-23 164.6 26.8 199 33-238 229-431 (441)
23 PF03023 MVIN: MviN-like prote 99.8 4.8E-17 1E-21 155.1 31.9 205 32-238 194-403 (451)
24 TIGR02900 spore_V_B stage V sp 99.8 2.2E-17 4.8E-22 160.4 26.7 204 30-238 219-434 (488)
25 COG0728 MviN Uncharacterized m 99.8 2E-15 4.3E-20 142.2 34.9 239 25-272 221-464 (518)
26 PF01554 MatE: MatE; InterPro 99.8 1.2E-19 2.5E-24 149.4 5.3 160 44-204 1-162 (162)
27 PRK10459 colanic acid exporter 99.8 2.4E-15 5.3E-20 146.2 35.2 200 32-237 203-404 (492)
28 PF01943 Polysacc_synt: Polysa 99.8 4.3E-15 9.4E-20 132.8 33.3 270 39-325 2-272 (273)
29 PRK15099 O-antigen translocase 99.8 3.9E-16 8.6E-21 148.3 26.3 203 28-237 207-411 (416)
30 COG2244 RfbX Membrane protein 99.7 1.8E-14 4E-19 139.7 26.4 190 28-223 205-396 (480)
31 PF13440 Polysacc_synt_3: Poly 99.6 1.2E-11 2.7E-16 109.1 31.2 246 55-324 3-250 (251)
32 PF01554 MatE: MatE; InterPro 99.5 1.9E-14 4.2E-19 118.2 5.8 133 265-399 1-133 (162)
33 TIGR00797 matE putative efflux 99.5 1.4E-12 3.1E-17 120.8 18.3 131 30-161 210-341 (342)
34 KOG1347 Uncharacterized membra 99.1 1.5E-10 3.3E-15 110.0 9.6 208 32-240 243-454 (473)
35 PF07260 ANKH: Progressive ank 99.0 2.6E-06 5.5E-11 74.4 29.1 316 33-357 8-343 (345)
36 PF04506 Rft-1: Rft protein; 98.7 2.4E-06 5.2E-11 82.8 21.2 203 35-238 252-470 (549)
37 PF14667 Polysacc_synt_C: Poly 98.6 1.1E-05 2.4E-10 64.7 17.7 79 158-238 2-80 (146)
38 PF04506 Rft-1: Rft protein; 98.6 4.3E-05 9.3E-10 74.2 24.5 356 41-398 6-405 (549)
39 KOG2864 Nuclear division RFT1 98.4 2.3E-05 5.1E-10 71.6 17.1 201 36-238 239-449 (530)
40 KOG2864 Nuclear division RFT1 98.1 0.0066 1.4E-07 56.1 26.7 357 35-399 7-386 (530)
41 PF01943 Polysacc_synt: Polysa 97.7 0.00031 6.8E-09 62.4 10.4 71 32-103 201-272 (273)
42 PF07260 ANKH: Progressive ank 97.4 0.0098 2.1E-07 52.5 14.9 139 254-399 8-150 (345)
43 COG4267 Predicted membrane pro 97.1 0.2 4.3E-06 45.5 27.5 264 86-372 74-360 (467)
44 PF13440 Polysacc_synt_3: Poly 96.9 0.01 2.3E-07 51.9 10.2 67 37-103 184-251 (251)
45 COG4267 Predicted membrane pro 91.1 11 0.00024 34.7 13.9 95 110-208 320-415 (467)
46 KOG0569 Permease of the major 75.4 84 0.0018 30.6 17.0 33 182-216 401-433 (485)
47 PF04505 Dispanin: Interferon- 75.0 23 0.0005 24.9 7.0 38 313-350 35-72 (82)
48 PF14184 YrvL: Regulatory prot 57.1 91 0.002 24.3 13.3 105 117-223 5-110 (132)
49 PF02487 CLN3: CLN3 protein; 38.8 73 0.0016 30.2 5.6 30 26-55 233-262 (402)
50 PF03904 DUF334: Domain of unk 35.0 2.1E+02 0.0045 24.5 7.0 38 108-145 142-179 (230)
51 TIGR00383 corA magnesium Mg(2+ 32.5 1.8E+02 0.0038 26.4 7.1 57 184-240 255-317 (318)
52 PF07782 DC_STAMP: DC-STAMP-li 31.0 1E+02 0.0022 25.7 4.7 52 12-63 26-77 (191)
53 PRK11085 magnesium/nickel/coba 30.7 3.5E+02 0.0076 24.7 8.4 58 183-240 252-315 (316)
54 KOG0637 Sucrose transporter an 27.6 2.2E+02 0.0048 27.6 6.6 103 36-150 32-135 (498)
55 PRK10739 putative antibiotic t 26.4 3.9E+02 0.0085 22.4 8.3 59 319-381 21-79 (197)
56 PF04505 Dispanin: Interferon- 24.3 2.6E+02 0.0056 19.6 6.1 32 96-127 40-71 (82)
57 COG2211 MelB Na+/melibiose sym 23.5 7E+02 0.015 24.3 23.1 32 34-65 10-41 (467)
58 PF06609 TRI12: Fungal trichot 22.5 8.2E+02 0.018 24.8 25.7 76 3-81 14-90 (599)
59 PF05975 EcsB: Bacterial ABC t 22.4 6.6E+02 0.014 23.6 16.2 40 108-147 89-130 (386)
60 PF01914 MarC: MarC family int 21.6 4.9E+02 0.011 21.9 8.9 58 320-381 22-79 (203)
No 1
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=100.00 E-value=1e-50 Score=385.02 Aligned_cols=365 Identities=22% Similarity=0.299 Sum_probs=346.0
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
++..|+++++++|++++++...+++.+|+.++||++++++++.+++.++..+. ..+..|++.|+++.++|++|+||+++
T Consensus 13 ~~~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~~~alaav~la~~i~~~~-~~~~~gl~~g~~~liaq~~Ga~~~~~ 91 (455)
T COG0534 13 KKILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLGAEALAAVGLANPIFFLI-IAIFIGLGTGTTVLVAQAIGAGDRKK 91 (455)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHHHH-HHHHHHHHHhHHHHHHHHHcCCchHH
Confidence 67899999999999999999999999999999999999999999999999998 89999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHH
Q 015819 112 IGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLS 190 (399)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 190 (399)
+++..++++.+.++++++..++ +.+.++++.+++.++++.+.+.+|+++..++.|+..++.++.+.+|+.|+++.+++.
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~m~~ 171 (455)
T COG0534 92 AKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKTPMYI 171 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchhHHH
Confidence 9999999999999999888877 999999999999988899999999999999999999999999999999999999999
Q ss_pred HHHHHHhHHHHHHHHhhh-cc-CccchhHHHHHHHHHHHHHHHHHHHHhccc-ccccCCCCChHHHhcHHHHHHHHhHHH
Q 015819 191 SCAALCLHIPICWSLVYK-SG-LGNLGGALAIGISNWLNVTFLAIYMKFSTA-CAESRVPISMELFQGIGEFFHFAIPSA 267 (399)
Q Consensus 191 ~~~~~~~~i~l~~~li~~-~~-~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~p~~ 267 (399)
++.++++|+++|++|+++ ++ +|+.|+++||.+++.+..+...++++++++ ......+..+.+++.+|++++.|+|.+
T Consensus 172 ~~~~~~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lG~p~~ 251 (455)
T COG0534 172 LLLGNLLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLLLIYLLRKKRLLSLFKKKLLKPDRKLLKEILRLGLPIF 251 (455)
T ss_pred HHHHHHHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhccCCCHHHHHHHHHhcccHH
Confidence 999999999999999998 57 999999999999999999999999988764 222223343456688999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH
Q 015819 268 VMICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVT 347 (399)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 347 (399)
+++..+...+...+.+.+++|+ +.+|+|+++.++.++.++++.|++++.+++++|++|+||+|++|+..+.+.++++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~G~--~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvG~~~Ga~~~~~a~~~~~~~~~~~~~ 329 (455)
T COG0534 252 LESLSESLGFLLLTLFVARLGT--VALAAYGIALRIASFIFMPPFGIAQAVTILVGQNLGAGNYKRARRAARLALKLSLL 329 (455)
T ss_pred HHHHHHHHHHHHHHHHHHhcCh--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999994 58999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 348 ETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 348 ~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
+++...++++++++++.++|++|+|+.+.+...+++..+.+++++.+.+.+|
T Consensus 330 ~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g 381 (455)
T COG0534 330 IALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSG 381 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999988764
No 2
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=100.00 E-value=1.1e-46 Score=357.55 Aligned_cols=353 Identities=14% Similarity=0.102 Sum_probs=323.5
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchh
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQ 110 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~ 110 (399)
.++.|+++++++|.+++++...+.+.+|+.+++|+ |++++++++++.++.++. ..+..+++.+.++.++|++|++|+|
T Consensus 5 ~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~g~~alAa~~l~~~i~~~~-~~~~~~~~~g~~~lvsq~~Ga~~~~ 83 (441)
T PRK10367 5 TSSDKALWRLALPMIFSNITVPLLGLVDTAVIGHLDSPVYLGGVAVGATATSFL-FMLLLFLRMSTTGLTAQAFGAKNPQ 83 (441)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 46789999999999999999999999999999999 778999999999999987 8899999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHH
Q 015819 111 RIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFL 189 (399)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 189 (399)
++++..++++.+++++++++.++ ..+.++++.+++.|+|+.+.+.+|+++.+++.|+..+..++.+.+|+.|+++.+++
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 163 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVI 163 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHH
Confidence 99999999999999999988877 78889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCC-CChHHHhcHHHHHHHHhHHHH
Q 015819 190 SSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVP-ISMELFQGIGEFFHFAIPSAV 268 (399)
Q Consensus 190 ~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~p~~~ 268 (399)
.++++.++|+++++++++.+++|+.|+++|+.+++.+..+...++++++++.++...+ ++.+.++.+|+++++|.|.++
T Consensus 164 ~~ii~~~vni~l~~~lI~~~~lGv~Gaa~At~is~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~ 243 (441)
T PRK10367 164 LLVVGNILNIVLDLWLVMGLHMNVQGAALATVIAEYATLLIGLLMVRKVLKLRGISLEMLKTAWRGNFRRLLALNRDIML 243 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHhhhhhHHHHHHHHHhCchHHH
Confidence 9999999999999999998889999999999999999988877776654321111111 111112468999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHH
Q 015819 269 MICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTE 348 (399)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 348 (399)
++..+...+.+.+.+++++|+ .++|+|+++.++.++.+++..|++++.+|+++|++|+||+|++|+..+.+.+++.++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~G~--~alAa~~I~~~i~~~~~~~~~gl~~a~~~lvg~~~Ga~~~~~a~~~~~~~~~~~~~~ 321 (441)
T PRK10367 244 RSLLLQLCFGAITVLGARLGS--DIIAVNAVLMTLLTFTAYALDGFAYAVEAHSGQAYGARDGSQLLDVWRAACRQSGIV 321 (441)
T ss_pred HHHHHHHHHHHHHHHHHhcCH--HHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999985 489999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHH
Q 015819 349 TIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLS 387 (399)
Q Consensus 349 ~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~ 387 (399)
+.+.+++++.+++++.++|++|+|+.+.+...+++..+.
T Consensus 322 ~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~ 360 (441)
T PRK10367 322 ALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVIL 360 (441)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999987644
No 3
>PRK10189 MATE family multidrug exporter; Provisional
Probab=100.00 E-value=3.5e-46 Score=357.29 Aligned_cols=371 Identities=15% Similarity=0.155 Sum_probs=336.2
Q ss_pred CCcchhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhh
Q 015819 24 SSTTWGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQA 103 (399)
Q Consensus 24 ~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~ 103 (399)
+++.|+ -+..|+++++++|.++++++..+...+|+.+++++|++++|+++++.++..+. ..+..|++.+.+++++|+
T Consensus 19 ~~~~~~--~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~lG~~alAA~~i~~~i~~~~-~~~~~gl~~g~~~lvsq~ 95 (478)
T PRK10189 19 KRKSYR--VLFWREITPLAVPIFIENLCVLLMGVLSTFLVSWLGKEAMAGVGLADSFNMVI-MAFFAAIDLGTTVVVAFS 95 (478)
T ss_pred hhhHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHH
Confidence 344565 36689999999999999999999999999999999999999999999999887 889999999999999999
Q ss_pred hCccchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcC--CChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHH
Q 015819 104 YGAQQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIG--QDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQS 180 (399)
Q Consensus 104 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~--~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~ 180 (399)
+|++|+|++++..+++..+++.++++.+++ +.+.++++.++. .|+|+.+.+.+|+++..++.|+..+...+.+++|+
T Consensus 96 ~Ga~~~~~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~ 175 (478)
T PRK10189 96 LGKRDRRRARAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRG 175 (478)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999988877 888999999994 68999999999999999999999999999999999
Q ss_pred cCchhHHHHHHHHHHHhHHHHHHHHhhh----ccCccchhHHHHHHHHHHHHHHHHHHHHhccc--ccccCCC-CChHHH
Q 015819 181 QSLIIPMFLSSCAALCLHIPICWSLVYK----SGLGNLGGALAIGISNWLNVTFLAIYMKFSTA--CAESRVP-ISMELF 253 (399)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~i~l~~~li~~----~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~ 253 (399)
.|+++.+++.++.+.++|+++++++++. +++|+.|+++|+.+++.+..+...+++.++++ .+..+++ +.+.++
T Consensus 176 ~G~~~~~~~i~~~~~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (478)
T PRK10189 176 AGNTKIPLLINGGMNILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAIIWVLMIGFNPALRISLKSYFKPLNF 255 (478)
T ss_pred cCchHHhHHHHHHHHHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeeccccccCCH
Confidence 9999999999999999999999999975 47999999999999999998877666654311 1111111 122346
Q ss_pred hcHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHH
Q 015819 254 QGIGEFFHFAIPSAVMICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQK 333 (399)
Q Consensus 254 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~ 333 (399)
+.+|++++.|+|.+++.........+.+.+++.+|+ .++|+|+++.++.++.+++..|++++..++++|++|+||+++
T Consensus 256 ~~~~~il~iG~P~~~~~~~~~~~~~~~~~~~~~~G~--~~~Aa~~I~~~i~~~~~~~~~gi~~A~~~lvg~~~Ga~~~~~ 333 (478)
T PRK10189 256 AIIWEVMGIGIPASIESVLFNGGKLLTQMFVAGMGT--SVIAGNFIAFSIAALINLPGNALGSASTIITGTRLGKGQIAQ 333 (478)
T ss_pred HHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHcCH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHH
Confidence 789999999999999999998888888888899984 589999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 334 ARVAVYAVIFMAVTETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
+|+..+.+..+++.+++.++++++.+++++.++|++|+|+.+.+...+++.++.+++++++.+.+|
T Consensus 334 a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g 399 (478)
T PRK10189 334 AERQLRHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPA 399 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999999999999999999999999999999999999999887654
No 4
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=100.00 E-value=1.6e-45 Score=352.67 Aligned_cols=365 Identities=21% Similarity=0.289 Sum_probs=331.8
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
+++.|+++++++|.+++++...+...+|+.+++|+|++++++++++.++.++. ..+..|++.+.++.++|++|++|+|+
T Consensus 6 ~~~~k~il~~a~P~~~~~~~~~~~~~~d~~~v~~lg~~alAa~~i~~~i~~~~-~~~~~gl~~~~~~i~aq~~Ga~~~~~ 84 (464)
T PRK00187 6 TTELKAILRLAGPLIASQLAHMLMVFTDTLMMGRLGPEALAGGGLGAASYSFV-SIFCVGVIAAVGTLVAIRHGAGDIEG 84 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCChhh
Confidence 57899999999999999999999999999999999999999999999999987 78899999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHH
Q 015819 112 IGTQTYTAIFCLFLVCFPLSFLWIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSS 191 (399)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 191 (399)
+++..+.+..+.++++++..++..+.++++.+++.|+|+.+.+.+|+++..++.++..+...+++++|+.|+++++++.+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~~~ 164 (464)
T PRK00187 85 ATRLAQAGLWLAWLLALVAALLLWNLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVMVIS 164 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHHHH
Confidence 99999999999999998877775567999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhHHHHHHHHhhh----ccCccchhHHHHHHHHHHHHHHHHHHHHhcccccc--cCCCCChHHHhcHHHHHHHHhH
Q 015819 192 CAALCLHIPICWSLVYK----SGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAE--SRVPISMELFQGIGEFFHFAIP 265 (399)
Q Consensus 192 ~~~~~~~i~l~~~li~~----~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~p 265 (399)
+.+.++|+++|++|++. +++|+.|+++|+.+++.+..+.+.++++++++.++ .+++..+.+++.+|++++.++|
T Consensus 165 ~~~~~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~lg~P 244 (464)
T PRK00187 165 LAGAVANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMALALALYIRRHPAYAAYPLRKGLSRPSRAALRELWRLGLP 244 (464)
T ss_pred HHHHHHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhccccCCCHHHHHHHHHhhhh
Confidence 99999999999999975 36899999999999998888776666655432211 1112223345778999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHH
Q 015819 266 SAVMICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMA 345 (399)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 345 (399)
.++++..+.....+++.+++++|+ .++|++++++++..+.++++.|++++..++++|++|+||+|++++..+.++.++
T Consensus 245 ~~~~~~~~~~~~~i~~~~i~~~G~--~alAa~~i~~~i~~l~~~~~~gi~~a~~~lvgq~~Ga~~~~~~~~~~~~~l~~~ 322 (464)
T PRK00187 245 IGGTYAVEVGLFTFAALCMGALGS--TQLAAHQIALQIVSVAFMVPVGLSYAVTMRVGQHYGAGRLLEARRAGRVGIGFG 322 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHH
Confidence 999999999999999999999985 589999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhhhccccC--ch---hHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 346 VTETIVVSATLFASRRVFGYVFSN--EK---QVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 346 ~~~~~~~~~~~~~~~~~i~~lf~~--d~---~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
..++++.++++.++++++.++|++ || |+.+.+..++++.+.+.++++++.+.+|
T Consensus 323 ~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~ 381 (464)
T PRK00187 323 AVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMG 381 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHH
Confidence 999999999999999999999964 44 7899999999999999999998887653
No 5
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=100.00 E-value=3.1e-45 Score=350.16 Aligned_cols=365 Identities=13% Similarity=0.099 Sum_probs=334.7
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchh
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQ 110 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~ 110 (399)
++..|+++++++|.+++++...+++.+|+.+++++ |++++++++++.++.++. ..+..+++.+.+++++|++|++|+|
T Consensus 8 ~~~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g~~~laa~~~~~~~~~~~-~~~~~~~~~g~~~lvsq~~Ga~~~~ 86 (453)
T PRK09575 8 QSIYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVGAEGLAGINMAWPVIGII-LGIGLMVGMGTGSLLSIKRGEGDLE 86 (453)
T ss_pred CchHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccccHHHHHHHHHHHHHHHHH-HHHHHHHhccHHHHHHHHhcCCCHH
Confidence 45789999999999999999999999999999996 999999999999999987 7788999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHH
Q 015819 111 RIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFL 189 (399)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 189 (399)
++++..++++.++.+++++.+++ +.+.++++.+++.|+++.+.+.+|+++..++.++..+.....+.+|+.|+++.+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 166 (453)
T PRK09575 87 KAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPNLATG 166 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 99999999999999999988877 88999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHH
Q 015819 190 SSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVM 269 (399)
Q Consensus 190 ~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 269 (399)
.++.+.++|+++++++++.+++|+.|+++|+.+++.+..++..++++++++..+...+..+.+++.+|++++.|+|..++
T Consensus 167 ~~~~~~~~ni~l~~~li~~~~~Gi~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~~ 246 (453)
T PRK09575 167 LMVIGALINIVLDYLFIGWLDWGLTGAAIATALAQLVVTVLGLGYFFSSRANIRLTLKELRFNWSLAPKIVLLGSSSFFM 246 (453)
T ss_pred HHHHHHHHHHHhhHHHHHhCCchhHHHHHHHHHHHHHHHHHHHHHHHCCCceeEEeeccCCcCHHHHHHHHHhChhHHHH
Confidence 99999999999999999888899999999999999999988777766543322221122233457789999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHH
Q 015819 270 ICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTET 349 (399)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 349 (399)
.....+...+.+.+.+++++. .++|+|+++.++..+.+++..|++++..|.++|++|+||+|++|+..+.++.+++..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~g~~-~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvg~~~Ga~~~~~~~~~~~~~l~l~~~~~ 325 (453)
T PRK09575 247 YLYGSFVVALHNRLFMEYGSA-LTVGAYAIVGYLMVLYYLVAEGIAEGMQPPVSYYFGARQYDNIKKLLKLAMKVTVLAG 325 (453)
T ss_pred HHHHHHHHHHHHHHHHHhCch-HHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHhcCCChHHHHHHHHHHHHHHHHHH
Confidence 999989999988888888853 4799999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhhhhhhccccC-chhHHHHHHHHHHHHHHHHHHhhhhhhcc
Q 015819 350 IVVSATLFASRRVFGYVFSN-EKQVVDYVTTMAPLVCLSVIMDSLQGVFS 398 (399)
Q Consensus 350 ~~~~~~~~~~~~~i~~lf~~-d~~~~~~~~~~l~~~~~~~~~~~~~~v~~ 398 (399)
++.++++..+++++.++|++ |||+.+.+...+++..++.++++++.+.+
T Consensus 326 ~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~ 375 (453)
T PRK09575 326 IAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLAS 375 (453)
T ss_pred HHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999995 78999999999999999999999887654
No 6
>PRK01766 multidrug efflux protein; Reviewed
Probab=100.00 E-value=1e-43 Score=341.09 Aligned_cols=365 Identities=20% Similarity=0.319 Sum_probs=335.2
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
++.+|+++++++|.+++++...+...+|+.+++++|++++++++++.++..+. ..+..|++.+..+.++|++|++|+|+
T Consensus 8 ~~~~~~il~~~~P~~~~~~~~~~~~~~d~~~i~~~g~~~laa~~~~~~~~~~~-~~~~~g~~~a~~~~vs~~~g~~~~~~ 86 (456)
T PRK01766 8 KSEARQLLALALPILLAQVAQTAMGFVDTVMAGGVSATDLAAVAIGTSIWLPV-ILFGHGLLLALTPIVAQLNGAGRRER 86 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCChHH
Confidence 67899999999999999999999999999999999999999999999998776 77889999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHH
Q 015819 112 IGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLS 190 (399)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 190 (399)
+++..+++..+.+.++++++++ +.+.+++..+++.|+++.+.+..|+++.+++.++..+..++.+++++.|+++++++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 166 (456)
T PRK01766 87 IAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPTMVI 166 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 9999999999999999988877 788899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhHHHHHHHHhhh----ccCccchhHHHHHHHHHHHHHHHHHHHHhccccc--ccCCCCChHHHhcHHHHHHHHh
Q 015819 191 SCAALCLHIPICWSLVYK----SGLGNLGGALAIGISNWLNVTFLAIYMKFSTACA--ESRVPISMELFQGIGEFFHFAI 264 (399)
Q Consensus 191 ~~~~~~~~i~l~~~li~~----~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 264 (399)
++.+.++|+++++++++. +++|+.|+++|+.+++++..+...++.+++++.. +.+.+..+.+++.+|++++.++
T Consensus 167 ~~i~~ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~l~~ 246 (456)
T PRK01766 167 GFLGLLINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRARRFRDFRLFKGLYKPDWAVIKRLLKLGL 246 (456)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhChhhhHHHhhccccCCCHHHHHHHHHccc
Confidence 999999999999999864 4689999999999999999998887776654321 1112222334567899999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHH
Q 015819 265 PSAVMICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFM 344 (399)
Q Consensus 265 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~ 344 (399)
|.+++...+...+.+++.+++++|+ +++++++++.++.++.++++.|++.+..+.++|++|+||++++|+..+.+..+
T Consensus 247 P~~~~~~~~~~~~~~~~~~~~~~G~--~~lAa~~i~~~i~~~~~~~~~gl~~a~~~~v~~~~Ga~~~~~~~~~~~~~~~~ 324 (456)
T PRK01766 247 PIGLAIFFEVSLFAVVTLLVSPLGT--VTVAAHQIALNFSSLLFMLPLSLAMALTIRVGFELGAGRTLDARQYAYIGLAV 324 (456)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHcCh--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 9999999999999999999999984 48999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 345 AVTETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
++.++++.++++..+++++.++|++|||+.+.+..++++..+..++++++.+.+|
T Consensus 325 ~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~ 379 (456)
T PRK01766 325 GLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSG 379 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999999999999999999999887765
No 7
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=100.00 E-value=2.6e-38 Score=292.99 Aligned_cols=338 Identities=26% Similarity=0.426 Sum_probs=308.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHHHHHHHHHHHH
Q 015819 44 PMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIGTQTYTAIFCL 123 (399)
Q Consensus 44 p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 123 (399)
|.+++++...+...+|+.+++++|++++++++++.++..+. ..+..|++++..+.++++.|++|+|++++..+....+.
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~a~~i~~~~-~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 79 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLGPVDLAAVSLGSSVFMFL-FSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLLA 79 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhcccHHHHHHHHHhHHHHHHH-HHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHHH
Confidence 78899999999999999999999999999999999998876 88899999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHhHHHHH
Q 015819 124 FLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAALCLHIPIC 202 (399)
Q Consensus 124 ~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~ 202 (399)
..++++.+++ +++.+++..+++.|++..+.+..+++++++..++..+..+..+.+++.||.+...+.++.+.+++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~~~~i~~~ 159 (342)
T TIGR00797 80 LLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGNVINIILN 159 (342)
T ss_pred HHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHHHHHHHHh
Confidence 9999998887 889999999998888888999999999999999999999999999999999999999999999999999
Q ss_pred HHHhh-hcc-CccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHHHHHHHHHHHHH
Q 015819 203 WSLVY-KSG-LGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVMICLEWWSFELL 280 (399)
Q Consensus 203 ~~li~-~~~-~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 280 (399)
+++++ ..+ +|+.|+++++.+++++..++..++.+++++.+..+++..+.+++.+|++++++.|..++++..++.+.++
T Consensus 160 ~~li~~~~g~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~ 239 (342)
T TIGR00797 160 YILIFGKFGFLGIVGAALATVISYWLMFLLLLYYIKKAKKIGLKWEGLLKPDWEVLKRLLKLGLPIAFRVILESLSFALL 239 (342)
T ss_pred HHHHhcCccccccHHHHHHHHHHHHHHHHHHHHHHHhCCCcccccccccCCCHHHHHHHHHhCchHHHHHHHHHHHHHHH
Confidence 99987 566 7899999999999999998887777664333222212222345678999999999999999999999999
Q ss_pred HHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHhhh
Q 015819 281 ILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTETIVVSATLFASR 360 (399)
Q Consensus 281 ~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 360 (399)
+.+++.++. .++++|+++.++.++..+++.+++++..|.+++++|+||.|+.++..+++.++.+.++++.+.++.+++
T Consensus 240 ~~i~~~~g~--~~v~~~~~a~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 317 (342)
T TIGR00797 240 ALLVARLGS--IALAAHQIALNVESLLFMPAFGFGIAVSILVGQALGAGDPKRAKEVARVALKLSLLLGLVLAIILILFR 317 (342)
T ss_pred HHHHHHcCc--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999988874 489999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhccccCchhHHHHHHHHHHHH
Q 015819 361 RVFGYVFSNEKQVVDYVTTMAPLV 384 (399)
Q Consensus 361 ~~i~~lf~~d~~~~~~~~~~l~~~ 384 (399)
+++.++|++|||+.+.+...+++.
T Consensus 318 ~~i~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T TIGR00797 318 EFIARLFTNDPEVLELAAIYLIFV 341 (342)
T ss_pred HHHHHHhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999888764
No 8
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=100.00 E-value=9.1e-34 Score=267.07 Aligned_cols=366 Identities=43% Similarity=0.736 Sum_probs=349.5
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
.++.|++.+++.|..+..+.......++..++||+|+.++++.+++....+.....+..|+..+..+.++|.+|+++++.
T Consensus 24 ~~e~k~l~~ia~P~i~~~~~~~~~~~is~~f~GhlG~leLaa~sla~s~~n~~~~s~~~gl~~aletlcgQa~ga~~~~~ 103 (473)
T KOG1347|consen 24 VTESKELARLALPAILTFLAQPLLSLVSTAFAGHLGNLELASVSLANSFANITGVSILLGLQLALDTLCGQAFGAKKFTA 103 (473)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhhccccchHHHHHHHHHHhhcccchHHhhccchhhhcchHhhhcccccch
Confidence 58899999999999999999999999999999999999999999999999987788999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHH
Q 015819 112 IGTQTYTAIFCLFLVCFPLSFLWIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSS 191 (399)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 191 (399)
.....+++.......+++.+.++.+.++++..+++|+++...+..|.++..+..+.+........++|++++..+..+..
T Consensus 104 lg~~lqrs~~~l~~~~~~~~~l~~~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~~~~ 183 (473)
T KOG1347|consen 104 LGVYLQRSGIVLLVQGLPISLLILNSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLLVIG 183 (473)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHHHH
Q 015819 192 CAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVMIC 271 (399)
Q Consensus 192 ~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 271 (399)
....++++++++++++.+++|..|++++..+++.+....+..+..... ..+.|..++.+ ++.++++++.++|.+++.-
T Consensus 184 ~~~~~lhi~~~~llv~~~~~g~~Gaala~~~s~w~~~~~l~~yi~~~~-~~~~w~~~s~~-~~~~~~~~~lai~s~~mic 261 (473)
T KOG1347|consen 184 LVALVLHILLTWLLVSKLGLGIKGAALALVASYWLNVRILLLYAVLSG-CLAAWSGFSGE-FDSWGPFFALAIPSAVMIC 261 (473)
T ss_pred HHHHHHHHHHHHHhhhcccCCCccchHHHHHHHHHHHHHHHHHheecC-chhhhhhhhHh-hhhHHHHHHHhhcchheeH
Confidence 999999999999999999999999999999999999999888877654 44556666666 7889999999999999999
Q ss_pred HHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH
Q 015819 272 LEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTETIV 351 (399)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 351 (399)
++++.+.+..+..+..+++..++++.++..++....++.+.+++.+.++++++.+|+++++++|...+.+...++..+..
T Consensus 262 lE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~~~~~~~~~~a~strv~neLGag~p~~ar~~~~v~~~~~~~~g~~ 341 (473)
T KOG1347|consen 262 LEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWHLMIPGAFSAAVSTRVSNELGAGKPKRARVSAKVALQTSVAIGAS 341 (473)
T ss_pred HHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHcCCChhhhhhHHHHHHHHHHHHHHH
Confidence 99999999999999999977899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 352 VSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 352 ~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
.+..+...++.+..+|++|+|+.+......++++...+.++.+.+.+|
T Consensus 342 ~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~G 389 (473)
T KOG1347|consen 342 LGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSG 389 (473)
T ss_pred HHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhh
Confidence 999999999999999999999999999999999999999999998876
No 9
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=100.00 E-value=2.4e-29 Score=245.04 Aligned_cols=352 Identities=13% Similarity=0.052 Sum_probs=288.7
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHH-HHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhCccchhHHHH
Q 015819 38 QGYIAAPMVAVTLSQYLLQVVSMMMVGH-LGQLAL-SSTAMAISLASVTGFSVL-LGMASALETLCGQAYGAQQYQRIGT 114 (399)
Q Consensus 38 i~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~-~~~~~a~~i~~~~~~~~~-~gl~~a~~~~~s~~~g~~~~~~~~~ 114 (399)
+.|-+.-..+++++..+.+++|..+++| +|++++ ++++++.++.+....... .|++++..+...++.+++ |++++
T Consensus 2 ~~k~~~i~~~~~~~~~~~~~~~~~~~a~~lG~~~~~~~~~~~~~i~~~~~~~~~~~g~~~a~i~~~~~~~~~~--~~~~~ 79 (502)
T TIGR01695 2 LLKSTLIVSLGTLFSRITGFVRDAIIASAFGAGLTADAFNVAFVIPNFFRRLFAEGAFNSAFVPVFTKAKKKE--KEARR 79 (502)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChHhhHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhh--hHHHH
Confidence 5677888899999999999999999999 599999 899999999876522323 468888777776654322 57777
Q ss_pred HHHHHHHHHH-HHHHHHHHH-HHhHHHHHHHc--CCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHH
Q 015819 115 QTYTAIFCLF-LVCFPLSFL-WIYAGKLLVLI--GQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLS 190 (399)
Q Consensus 115 ~~~~~~~~~~-~~~~~~~~~-~~~~~~i~~~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 190 (399)
....+..... ..+++..++ +++++++..++ +.+++..+.+..|++++.++.++..+.....+++|+.++.+.+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 159 (502)
T TIGR01695 80 AFANTVTTLLILSLLLVVLIGIFFAPFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPSFS 159 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHHHH
Confidence 7766655544 444444555 78888898888 4466777889999999999999999999999999999999999999
Q ss_pred HHHHHHhHHHHHHHHhhhccCccchhH--HHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHH
Q 015819 191 SCAALCLHIPICWSLVYKSGLGNLGGA--LAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAV 268 (399)
Q Consensus 191 ~~~~~~~~i~l~~~li~~~~~g~~G~~--~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 268 (399)
++...++++...+++. +++|..|++ +++.++..+..+...++.+|++.. .+.+++ .+++.+|++++++.|..+
T Consensus 160 ~i~~~i~~i~~~~~~~--~~~g~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~-~~~~~~k~~l~~~~p~~~ 234 (502)
T TIGR01695 160 PILFNIGVILSLLFFD--WNYGQYSLALAIGVLIGGVAQLLIQLPFLRKAGFL--LKPRFN-FRDPGLKRFLKLFLPTTL 234 (502)
T ss_pred HHHHHHHHHHHHHHHH--cccchHHHHHHHHHHHHHHHHHHHHHHHHHHCCCc--ccCcCC-CCChhHHHHHHHHHHHHH
Confidence 9988888777544443 568999988 999999999888877666554311 111121 134668999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHH
Q 015819 269 MICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYA-IPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVT 347 (399)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~-~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 347 (399)
++....+...+++.+.+.+++ .++++|+.+.++.++... +..+++++..|.+++++|+||.++.++..+++.++...
T Consensus 235 ~~~~~~~~~~id~~~~~~~~~--~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~~~~~~~~~~~~~~~~ 312 (502)
T TIGR01695 235 GSSASQITLLINTALASFLEI--GSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWNELRDLLNQGIRLSLL 312 (502)
T ss_pred HHHHHHHHHHHHHHHHhcCCc--chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHH
Confidence 999999999999988777764 378999999999998765 57899999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhhhhhhccccC----chhHHHHHHHHHHHHHHHHHHhhhhhhcc
Q 015819 348 ETIVVSATLFASRRVFGYVFSN----EKQVVDYVTTMAPLVCLSVIMDSLQGVFS 398 (399)
Q Consensus 348 ~~~~~~~~~~~~~~~i~~lf~~----d~~~~~~~~~~l~~~~~~~~~~~~~~v~~ 398 (399)
++++.++++..+++++.++|.+ |+|..+.+...+++++++.++.+++.+..
T Consensus 313 ~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 367 (502)
T TIGR01695 313 LTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLL 367 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999998865 56788889999999999999988877653
No 10
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=100.00 E-value=2.5e-29 Score=244.09 Aligned_cols=351 Identities=12% Similarity=0.105 Sum_probs=287.2
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHHHHHH
Q 015819 39 GYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIGTQTY 117 (399)
Q Consensus 39 ~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~~ 117 (399)
.|-+.|.+++++...+..++|..+++|+ |++++|+++.+.++.++.......|++.+..+.++|..|++|+|+.++.++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~~~l~r~Lg~~~~G~~~~~~~~~~~~~~~~~~Gl~~a~~~~is~~~~~~~~~~~~~~~~ 81 (488)
T TIGR02900 2 LKGTFILTIANLITRILGFIFRIVLSRILGAEGVGLYGMAMPIYFLFITLTTGGLPVAISKFVAEASAKNDRKNIKKILK 81 (488)
T ss_pred hHhHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhhHHHHHHHHHHHHHHHHhCCcHHHHHHHHHHHHhccchhhHHHHHH
Confidence 4678999999999999999999999995 999999999999998876333446999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHH
Q 015819 118 TAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAALC 196 (399)
Q Consensus 118 ~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 196 (399)
.++.+....+++++++ +.+.+++...+.+|++. ..++++.++..++..+.....+.+|+.+|.+.....++.+.+
T Consensus 82 ~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~i~~i 157 (488)
T TIGR02900 82 VSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERS----LYSLLVICPAMPFIALSSVLKGYFQGISNMKPPAYIQVIEQI 157 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhH----HHHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHHHHHHHHH
Confidence 9999999999888877 78888888777666543 346788889999999999999999999999999999999999
Q ss_pred hHHHHHHHHhhh-----ccCccchhHHHHHHHHHHHHHHHHHHHHhcccccc--cCCCCChHHHhcHHHHHHHHhHHHHH
Q 015819 197 LHIPICWSLVYK-----SGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAE--SRVPISMELFQGIGEFFHFAIPSAVM 269 (399)
Q Consensus 197 ~~i~l~~~li~~-----~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~p~~~~ 269 (399)
+++.++..++.. .++|+.|+++++.++..+..+...++.+++++.+. ...+..+.+++.+|+++++++|..++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~~~~~p~~l~ 237 (488)
T TIGR02900 158 VRISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRKKSFSIRFPFFDYKSEGKALLFDLFSVSLPLTLS 237 (488)
T ss_pred HHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccCcchHHHHHHHHHHHHHHHHH
Confidence 998776655432 24678888899999999988887766655433211 11111233456789999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCC-----hhH---HHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHH
Q 015819 270 ICLEWWSFELLILMSGLLPN-----PQL---ETSVL-SVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYA 340 (399)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~-----~~~---~~a~~-~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~ 340 (399)
+.........+++++++... ... ..+.| +++.++.++...+..+++++..|.++++.|+||+++.++..++
T Consensus 238 ~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~~~~~~~l~~~~~p~~s~~~~~~~~~~~~~~~~~ 317 (488)
T TIGR02900 238 RFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFPAVITSSLSTALVPDISEAMAKKNYSSIEKRINQ 317 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHHHHH
Confidence 99999999999888765321 011 23333 4566788888888899999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhhc
Q 015819 341 VIFMAVTETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVF 397 (399)
Q Consensus 341 ~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~ 397 (399)
..+++..++++.++++..+++++.++|.++++ +.+.+++.+...++.+++.+.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~----~~~~l~i~~~~~~~~~~~~~~ 370 (488)
T TIGR02900 318 AIKISLLLGLITTVILLVIPDELGALFYGRPD----AGNFIRVLAPSFPFLYFSAPL 370 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCc----hHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999998876554 456778888888877776653
No 11
>PRK15099 O-antigen translocase; Provisional
Probab=99.97 E-value=5.6e-28 Score=229.46 Aligned_cols=338 Identities=11% Similarity=0.025 Sum_probs=275.9
Q ss_pred HHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHHHHH
Q 015819 38 QGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIGTQT 116 (399)
Q Consensus 38 i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~ 116 (399)
+.|.+.....++++..+.+++...+++|+ |++++|.++..+++..+.......|++++..+.++|+ ++|+|+.++.+
T Consensus 3 ~~k~~~~~~~~~~~~~~~~~l~~~i~ar~Lg~~~~G~~~~~~~~i~~~~~~~~~G~~~a~~~~ia~~--~~~~~~~~~~~ 80 (416)
T PRK15099 3 LAKASLWTAASTLVKIGAGLLVVKLLAVSFGPAGVGQAGNFRQLITVLGVLAGAGIFNGVTKYVAQY--HDQPQQLRAVV 80 (416)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCcHHHHHHHHHHHHHHHHHHHHcCCccceeeeeHHhc--CCCHHHHHHHH
Confidence 56777788889999999999999999996 9999999999999998774545788888888999988 67888999999
Q ss_pred HHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHH
Q 015819 117 YTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAAL 195 (399)
Q Consensus 117 ~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 195 (399)
+.++.+.+..+++++++ +.+.+++...+..+++. ..++.+..+..++..+.....+.+|+.|+.+..+...+.+.
T Consensus 81 ~~~~~l~~~~~~i~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lr~~~~~~~~~~~~~~~~ 156 (416)
T PRK15099 81 GTSSAMVLGFSTLLALVFLLAAAPISQGLFGHTDY----QGVVRAVALIQMGIAWANLLLAILKGFRDAAGNALSLIVGS 156 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999998877 88889999888776642 34566666767777888899999999999999999999999
Q ss_pred HhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHHHHHHHH
Q 015819 196 CLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVMICLEWW 275 (399)
Q Consensus 196 ~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 275 (399)
++|+.+ +++.... .|+.|+++|+.+++.+..+...++.+++++.+..+.+.+ .+++.+|+++++|.|..+++....+
T Consensus 157 ~~~i~l-~i~~~~~-~Gv~Ga~iat~i~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~k~ll~~g~p~~~~~~~~~i 233 (416)
T PRK15099 157 LIGVAA-YYLCYRL-GGYEGALLGLALVPALVVLPAGIMLIRRGTIPLSYLKPS-WDNGLAGQLGKFTLMALITSVTLPV 233 (416)
T ss_pred HHHHHH-HHHHHHH-hcchHHHHHHHHHHHHHHHHHHHHHHHccceehHhhhcc-CCHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999887 4444332 499999999999999988877776665433211111222 2356789999999999999999999
Q ss_pred HHHHHHHHHh-cCCChhHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHH
Q 015819 276 SFELLILMSG-LLPNPQLETSVLSVCLNTIQT-LYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTETIVVS 353 (399)
Q Consensus 276 ~~~~~~~~~~-~~~~~~~~~a~~~i~~~i~~~-~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 353 (399)
....++.+++ .+| ..++|.|+++.++.+. ...+..+++++..|.+++. +|.||.++..++..+....++.+.+
T Consensus 234 ~~~~~~~~l~~~~g--~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (416)
T PRK15099 234 AYVMMRNLLAAHYS--WDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---TEKRDITREIVKALKFVLPAVAAAS 308 (416)
T ss_pred HHHHHHHHHHhcCC--HHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CChHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999998886 666 3499999999999874 5789999999999999995 6788999999999999999999999
Q ss_pred HHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHh
Q 015819 354 ATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMD 391 (399)
Q Consensus 354 ~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~ 391 (399)
+++.++++++.++|.+|+ ++...+.+++.+.+.++.
T Consensus 309 ~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~ 344 (416)
T PRK15099 309 FTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLK 344 (416)
T ss_pred HHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHH
Confidence 999999999999988765 233455555555444443
No 12
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.93 E-value=1.1e-21 Score=186.97 Aligned_cols=324 Identities=12% Similarity=0.107 Sum_probs=275.6
Q ss_pred cChh-HHHHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHhhhCccchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHH
Q 015819 66 LGQL-ALSSTAMAISLASVTGFSVL-LGMASALETLCGQAYGAQQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLV 142 (399)
Q Consensus 66 ~g~~-~~~~~~~a~~i~~~~~~~~~-~gl~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~ 142 (399)
+|.. +..+|.++.++.+++...+. .++.++..|...+.. ++++|+.++..+..........+.++++ +++++++.+
T Consensus 5 fG~s~~~Daf~~A~~ip~~l~~l~~~gal~~~~IP~~~~~~-~~~~~~~~~f~~~~~~~~~~~~~~l~~l~~lfa~~iv~ 83 (451)
T PF03023_consen 5 FGASAEADAFFVAFTIPNFLRSLLAGGALSAAFIPVFSKAR-EKGEEEARRFISTLLTILLIISLLLTLLGILFAPPIVR 83 (451)
T ss_pred hcCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4544 56789999999998743444 468999999999998 8888999999999888888888888877 899999999
Q ss_pred Hc--CCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHhHHHHHHHHhhhccCc---cchhH
Q 015819 143 LI--GQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAALCLHIPICWSLVYKSGLG---NLGGA 217 (399)
Q Consensus 143 ~~--~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g---~~G~~ 217 (399)
++ +.|++..+.+.++++++.+..++..+..++.+++|+.+|...+....+..++..++..+++.. ..| +.+.+
T Consensus 84 ~la~g~~~~~~~la~~l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~~~l~~N~~~I~~~~~~~~--~~~~~~i~~la 161 (451)
T PF03023_consen 84 LLAPGFSPETIELAVQLLRILAPSILFIGLSSIFSAILNAHRRFLIPALSPLLFNLSIILSLLLLSN--SWGQENIYALA 161 (451)
T ss_pred HHCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHHHHHHHHHHHHHHHHHHHH--hcCchHHHHHH
Confidence 88 457788999999999999999999999999999999999999988887777776665554443 366 88899
Q ss_pred HHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCChhHHHHHH
Q 015819 218 LAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVMICLEWWSFELLILMSGLLPNPQLETSVL 297 (399)
Q Consensus 218 ~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~ 297 (399)
+|..++.++..+..+...+|.+...+.. ++.+ .+..|+.++...|..+......+...+++.+++.++.+ ++++.
T Consensus 162 ~g~~~g~~~~~l~~l~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G--~vs~l 236 (451)
T PF03023_consen 162 WGVLIGAIIQFLIQLPYLRRFGFRFRPK--FDWR-DPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEG--SVSAL 236 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCCccccc--CCCC-ChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCcc--HHHHH
Confidence 9999999999998888877664332221 2221 14588999999999999999999999999999998855 79999
Q ss_pred HHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhcccc----Cchh
Q 015819 298 SVCLNTIQTLY-AIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTETIVVSATLFASRRVFGYVFS----NEKQ 372 (399)
Q Consensus 298 ~i~~~i~~~~~-~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~----~d~~ 372 (399)
+.+.++.++.. .+..+++++..|.++++..++|.++.++..+++++....+.+|.++.+..+++++.++.. -|+|
T Consensus 237 ~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~~~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~ 316 (451)
T PF03023_consen 237 NYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWEEFRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAE 316 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHH
Confidence 99999999988 556799999999999999999999999999999999999999999999999999998742 3677
Q ss_pred HHHHHHHHHHHHHHHHHHhhhhhhc
Q 015819 373 VVDYVTTMAPLVCLSVIMDSLQGVF 397 (399)
Q Consensus 373 ~~~~~~~~l~~~~~~~~~~~~~~v~ 397 (399)
..+.....+++++.+.++.+++.++
T Consensus 317 ~~~~ta~~l~~y~~~l~~~~l~~ll 341 (451)
T PF03023_consen 317 DTQLTASALRIYALGLPFYALNDLL 341 (451)
T ss_pred HHHHHHHHHHHHHHHhHHHHHHHHH
Confidence 7889999999999999999987654
No 13
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=99.92 E-value=5.1e-23 Score=197.42 Aligned_cols=208 Identities=18% Similarity=0.233 Sum_probs=192.6
Q ss_pred hhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccch
Q 015819 30 VLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQY 109 (399)
Q Consensus 30 ~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~ 109 (399)
..++..|++++.++|.+++++.......+|..+++++|++++++++++.++.++. ..+..|++.|.+++++|++|++|+
T Consensus 230 ~~~~~~k~il~lg~P~~~~~~~~~~~~~i~~~~i~~~G~~alAa~~i~~~i~~l~-~~~~~gi~~a~~~lvgq~~Ga~~~ 308 (464)
T PRK00187 230 PSRAALRELWRLGLPIGGTYAVEVGLFTFAALCMGALGSTQLAAHQIALQIVSVA-FMVPVGLSYAVTMRVGQHYGAGRL 308 (464)
T ss_pred CCHHHHHHHHHhhhhHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHcCCCH
Confidence 3467899999999999999999999999999999999999999999999999987 889999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCC--Ch---hHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCc
Q 015819 110 QRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQ--DP---QISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSL 183 (399)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~--~~---~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~ 183 (399)
|++++..+.+..++...+++.+++ +.+.+++.+++.+ |+ |+.+.+..|+++.+++.++..++.++.+++|+.|+
T Consensus 309 ~~~~~~~~~~l~~~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~G~ 388 (464)
T PRK00187 309 LEARRAGRVGIGFGAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGLKD 388 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhccCc
Confidence 999999999999999999988877 8899999999953 43 68889999999999999999999999999999999
Q ss_pred hhHHHHHHHHHH-HhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 184 IIPMFLSSCAAL-CLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 184 ~~~~~~~~~~~~-~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
++.+++.++... ++++++++++.+.+++|+.|+|+++.+++++..+.....++++
T Consensus 389 ~~~~~~~~~~~~~~~~ipl~~ll~~~~~~g~~Gvw~~~~i~~~~~~~~~~~~~~~~ 444 (464)
T PRK00187 389 ARTTFLIGLACYWLVGAPLAWLLAFTLGWGAVGVWWGLALGLACAAVALTLAFEWK 444 (464)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHhccCCCceeeHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999885 9999999999988889999999999999999988776666443
No 14
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.92 E-value=1.8e-20 Score=175.95 Aligned_cols=359 Identities=14% Similarity=0.054 Sum_probs=293.9
Q ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-Ch-hHHHHHHHHHHHHHHHHHHHHHH-HHHhHHHHHHhhhCccchh
Q 015819 34 EVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQ-LALSSTAMAISLASVTGFSVLLG-MASALETLCGQAYGAQQYQ 110 (399)
Q Consensus 34 ~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~-~~~~~~~~a~~i~~~~~~~~~~g-l~~a~~~~~s~~~g~~~~~ 110 (399)
..+.++|.++-....++++.+.+++-..+++++ |+ ....++.+|.++.+++--.+..| ++++..|...++..+++.|
T Consensus 5 ~~~sllks~~~vs~~Tl~SRi~G~vRd~~iA~~fGa~~~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~~~~ 84 (518)
T COG0728 5 SKMSLLKSLIIVSSATLLSRILGFVRDVLIAAAFGAGAAADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKEGEE 84 (518)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCchHHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcchhh
Confidence 345677777777888888888889988888885 87 46789999999999875555554 6899999999998877777
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHc-CC--ChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhH
Q 015819 111 RIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLI-GQ--DPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIP 186 (399)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~-~~--~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 186 (399)
+.++...........+.+.++++ .++++++.+.. .. |++....+....+++.|..++..+.....+++++.+|...
T Consensus 85 ~~~~f~~~v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~F~~ 164 (518)
T COG0728 85 AARFFSRLVTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNRFFI 164 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeech
Confidence 77777777776666777777777 88888888554 33 2333335778889999999999999999999999999999
Q ss_pred HHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHH
Q 015819 187 MFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPS 266 (399)
Q Consensus 187 ~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 266 (399)
+.+..+..++.-+...+.+....+.-..+.+++..++.++..++.+..++|.+...+.+..++. +.+|++.+...|.
T Consensus 165 ~a~aPvl~Nv~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~g~~~~p~~~~~~---~~lk~~~~~~~p~ 241 (518)
T COG0728 165 PAFAPVLLNVSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKAGLLIKPRFGFKD---PGLKRFLKLMLPA 241 (518)
T ss_pred hhhhHHHHHHHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHcccccCCCCCCCc---hhHHHHHHHHHHH
Confidence 9988887777777555555443222366889999999999999999999887533232222221 5688999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHH
Q 015819 267 AVMICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLY-AIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMA 345 (399)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~-~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 345 (399)
.+.....++...+++.+++...++ +++.++.++++.++.. .+..++++...|.++++..++|.++.++..+.+++.+
T Consensus 242 ~l~~sisQi~lli~~~iAS~l~~G--sis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~~~~~~l~~~i~l~ 319 (518)
T COG0728 242 LLGVSISQINLLIDTAIASFLAEG--SVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWPEFLKLLDWGLRLT 319 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHhhccc--cHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChHHHHHHHHHHHHHH
Confidence 999999999999999999999754 7888999999999999 6779999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhhhccc-c---CchhHHHHHHHHHHHHHHHHHHhhhhhhc
Q 015819 346 VTETIVVSATLFASRRVFGYVF-S---NEKQVVDYVTTMAPLVCLSVIMDSLQGVF 397 (399)
Q Consensus 346 ~~~~~~~~~~~~~~~~~i~~lf-~---~d~~~~~~~~~~l~~~~~~~~~~~~~~v~ 397 (399)
+.+++|.+..+.++++++.++. . -+++......+.+..++++.++.++.-++
T Consensus 320 lll~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll 375 (518)
T COG0728 320 LLLTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLL 375 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHH
Confidence 9999999999999999999864 2 25667888999999999999988876543
No 15
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=99.92 E-value=8.2e-23 Score=194.45 Aligned_cols=214 Identities=19% Similarity=0.226 Sum_probs=201.0
Q ss_pred cchhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhC
Q 015819 26 TTWGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYG 105 (399)
Q Consensus 26 ~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g 105 (399)
+.++.+++..|++++.++|..++++.......+.+.+++++|++.+|+++++.++.++. ..+..|+++|++++++|++|
T Consensus 231 ~~~~~~~~~~~~i~~lG~p~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~~~-~~~~~gi~~a~~~lvG~~~G 309 (455)
T COG0534 231 KLLKPDRKLLKEILRLGLPIFLESLSESLGFLLLTLFVARLGTVALAAYGIALRIASFI-FMPPFGIAQAVTILVGQNLG 309 (455)
T ss_pred hccCCCHHHHHHHHHhcccHHHHHHHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhC
Confidence 34455678999999999999999999999999999999999999999999999999998 99999999999999999999
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCch
Q 015819 106 AQQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLI 184 (399)
Q Consensus 106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~ 184 (399)
++|+|++++..+.+..++..+++..+++ +++++++..+|.+|+++.+.+..++++..+..++...+.+..+.+||.|++
T Consensus 310 a~~~~~a~~~~~~~~~~~~~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~ 389 (455)
T COG0534 310 AGNYKRARRAARLALKLSLLIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDA 389 (455)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999988 999999999999999999999999999999999999999999999999999
Q ss_pred hHHHHHHHHH-HHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccc
Q 015819 185 IPMFLSSCAA-LCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTAC 241 (399)
Q Consensus 185 ~~~~~~~~~~-~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~ 241 (399)
+.+++.++.+ +++.+++.+++.+.. +|..|+|++...++.+..+...+++++++|.
T Consensus 390 ~~~~~~~~~~~~~~~lp~~~~l~~~~-~g~~Gvw~~~~~~~~~~~~~~~~~~~~~~~~ 446 (455)
T COG0534 390 KIPFIISLLSYWGFRLPLAYLLGFFF-LGLAGVWIGFPLSLILRAILLLLRLRRGRWR 446 (455)
T ss_pred HHHHHHHHHHHHHHHHhHHHHHhhhc-ccchHHHHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 9999999886 777888888888665 8999999999999999999999988877543
No 16
>PRK10189 MATE family multidrug exporter; Provisional
Probab=99.91 E-value=3e-22 Score=192.29 Aligned_cols=211 Identities=15% Similarity=0.063 Sum_probs=196.7
Q ss_pred hHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchh
Q 015819 31 LSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQ 110 (399)
Q Consensus 31 ~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~ 110 (399)
+++.+|++++.++|..++.........+.+.+++++|++++++++++.++.++. ..+..|+++|.+++++|++|++|.|
T Consensus 254 ~~~~~~~il~iG~P~~~~~~~~~~~~~~~~~~~~~~G~~~~Aa~~I~~~i~~~~-~~~~~gi~~A~~~lvg~~~Ga~~~~ 332 (478)
T PRK10189 254 NFAIIWEVMGIGIPASIESVLFNGGKLLTQMFVAGMGTSVIAGNFIAFSIAALI-NLPGNALGSASTIITGTRLGKGQIA 332 (478)
T ss_pred CHHHHHHHHHHhccHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 467899999999999999999999999999999999999999999999999997 8899999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHH
Q 015819 111 RIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFL 189 (399)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 189 (399)
++++..+.+..++...++.++++ +++++++..+|.+|+|+.+.+..++++.++..++...+.+..+.+||.|+++.+++
T Consensus 333 ~a~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~~ 412 (478)
T PRK10189 333 QAERQLRHVFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAMW 412 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHHH
Confidence 99999999999999999988888 88999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHH-HHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhccccc
Q 015819 190 SSCAA-LCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACA 242 (399)
Q Consensus 190 ~~~~~-~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~ 242 (399)
.++.. +++.+++.+++....++|+.|+|++..+++.+..+...+.+++.+|.+
T Consensus 413 i~~~~~~~v~ip~~~ll~~~~~~g~~Gvw~~~~~~~~~~~~~~~~r~~~~~W~~ 466 (478)
T PRK10189 413 VSMLGMWGCRVVAGYILGIMLGFGVVGVWMGMFLDWAVRGVLFYWRMVSGRWLW 466 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 88776 678888988887767899999999999999999998888887776655
No 17
>PRK01766 multidrug efflux protein; Reviewed
Probab=99.91 E-value=3.6e-22 Score=191.94 Aligned_cols=206 Identities=16% Similarity=0.213 Sum_probs=194.5
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
++..|++++.++|.+++++.......++..+++++|++++++++++.++.++. ..+..|++.+.++.++|++|++|+|+
T Consensus 235 ~~~~k~il~l~~P~~~~~~~~~~~~~~~~~~~~~~G~~~lAa~~i~~~i~~~~-~~~~~gl~~a~~~~v~~~~Ga~~~~~ 313 (456)
T PRK01766 235 WAVIKRLLKLGLPIGLAIFFEVSLFAVVTLLVSPLGTVTVAAHQIALNFSSLL-FMLPLSLAMALTIRVGFELGAGRTLD 313 (456)
T ss_pred HHHHHHHHHccchHHHHHHHHHHHHHHHHHHHHHcChHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhcCCCHHH
Confidence 67899999999999999999999999999999999999999999999999987 88999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHH
Q 015819 112 IGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLS 190 (399)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 190 (399)
+++..+.+..++..++++.+++ +.+.+++..++.+|+++.+.+..|+++..+..++..++.+..+.+|+.|+++.+++.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~~~~ 393 (456)
T PRK01766 314 ARQYAYIGLAVGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVIFFI 393 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHHHHH
Confidence 9999999999999999988877 889999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHH-HhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 191 SCAAL-CLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 191 ~~~~~-~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
++.+. ++++++.+++.+.+++|+.|+|+++.+++++..++.++++++.
T Consensus 394 ~~~~~~~~~i~~~~~l~~~~~~G~~G~~~~~~~~~~~~~~~~~~~~~~~ 442 (456)
T PRK01766 394 TFIAYWVLGLPLGYILALTDPMGPFGFWIGLIIGLTAAAILLLLRLRKL 442 (456)
T ss_pred HHHHHHHHHHHHHHHHHhccCCCceehHHHHHHHHHHHHHHHHHHHHHH
Confidence 99875 7899999998887889999999999999999999887777654
No 18
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=99.91 E-value=9.8e-22 Score=188.24 Aligned_cols=208 Identities=17% Similarity=0.146 Sum_probs=190.6
Q ss_pred hhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccCh-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCc
Q 015819 28 WGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQ-LALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGA 106 (399)
Q Consensus 28 ~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~-~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~ 106 (399)
++.+++..|++++.+.|..+++....+...+.+.+++++|+ +++++++++.++.++. ..+..|++.+.++.++|++|+
T Consensus 226 ~~~~~~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~g~~~~lAa~~i~~~i~~~~-~~~~~gi~~a~~~lvg~~~Ga 304 (453)
T PRK09575 226 LRFNWSLAPKIVLLGSSSFFMYLYGSFVVALHNRLFMEYGSALTVGAYAIVGYLMVLY-YLVAEGIAEGMQPPVSYYFGA 304 (453)
T ss_pred CCcCHHHHHHHHHhChhHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHHHHHHHHH-HHHHHHHHHhhHHHHHHHhcC
Confidence 34446789999999999999999999999999999999975 6899999999999987 889999999999999999999
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCC-ChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCch
Q 015819 107 QQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQ-DPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLI 184 (399)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~ 184 (399)
+|+|++++..+.+..+++..+++.+++ +.+.+++..+++. |+|+.+.+..|+++.+++.++.....+..+++|+.|++
T Consensus 305 ~~~~~~~~~~~~~l~l~~~~~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~ 384 (453)
T PRK09575 305 RQYDNIKKLLKLAMKVTVLAGIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQG 384 (453)
T ss_pred CChHHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCc
Confidence 999999999999999999999999988 8899999999985 78999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 185 IPMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 185 ~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
+..++.++...++++++.+++... +|+.|+|+++.+++.+..+...+.++++
T Consensus 385 ~~~~~~~~~~~~v~ip~~~ll~~~--~G~~Gvw~a~~~~~~~~~~~~~~~~~~~ 436 (453)
T PRK09575 385 GKALFISIGNMLIQLPFLFILPKW--LGVDGVWLAMPLSNIALSLVVAPMLWRD 436 (453)
T ss_pred HHHHHHHHHhHHHHHHHHHHHHHH--HCcchHhhHHHHHHHHHHHHHHHHHHHH
Confidence 999999988888899998888643 7999999999999999888877666553
No 19
>PRK10459 colanic acid exporter; Provisional
Probab=99.89 E-value=1.3e-19 Score=176.03 Aligned_cols=335 Identities=10% Similarity=0.063 Sum_probs=254.3
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHH
Q 015819 35 VKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIG 113 (399)
Q Consensus 35 ~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~ 113 (399)
.++..+-+....+++.......++...+++|+ |++++|.++.+..+.++.......|++.+.. |.. +++ +
T Consensus 4 ~~~~~~g~~w~~~~~~~~~~~~~i~~~ilaR~L~p~~~G~~~~~~~~~~~~~~~~~~Gl~~aii----~~~-~~~----~ 74 (492)
T PRK10459 4 REKTISGAKWTAISTVIIIGLQLVQLTVLARILDNHQFGLLTMSLVIIGFADTLSDMGIGASII----QRQ-DIS----H 74 (492)
T ss_pred HHHHHccccHHHHHHHHHHHHHHHHHHHHHHhCCHHHccHHHHHHHHHHHHHHHHHcCHHHHHH----hcc-cCC----H
Confidence 46677888889999999999999999999995 9999999999999999874555667777643 221 112 2
Q ss_pred HHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHH
Q 015819 114 TQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSC 192 (399)
Q Consensus 114 ~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 192 (399)
+.....+.+....++++.++ +.+.+++..+++ +++. ...+++..+..++..+.......+++.++.+.......
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~~ 149 (492)
T PRK10459 75 LQLSTLYWLNVGLGIVVFVLVFLLSPLIADFYH-NPEL----APLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIEI 149 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC-Chhh----HHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHHH
Confidence 33445556666677666666 666666665554 4432 34567777888888888888999999999888888788
Q ss_pred HHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHHHHH
Q 015819 193 AALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVMICL 272 (399)
Q Consensus 193 ~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 272 (399)
...+....+.+.+.. .++|+.+..++..++..+..+...... ++++.. ..++ +++..|++++++.|...++..
T Consensus 150 ~~~i~~~~~~i~~~~-~~~g~~~l~~~~~~~~~~~~l~~~~~~-~~~~~~--~~~~---~~~~~k~ll~~~~~~~~~~~~ 222 (492)
T PRK10459 150 SAVVAGFTFAVVSAF-FWPGALAAILGYLVNSSVRTLLFGYFG-RKIYRP--ALHF---SLASVKPNLSFGAWQTAERII 222 (492)
T ss_pred HHHHHHHHHHHHHHH-HCCcHHHHHHHHHHHHHHHHHHHHHHh-cccCCc--ccee---cHHHHHHHHhhhHHHHHHHHH
Confidence 887777777666554 368899999999999888776543322 222111 1111 235678999999999999999
Q ss_pred HHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHH
Q 015819 273 EWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYA-IPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTETIV 351 (399)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~-~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 351 (399)
..+....++++++.+.++ .++|.|+.++++.++... +...+++...|.+++. ++|.++.++..++..++...+++|
T Consensus 223 ~~~~~~~d~~~lg~~lg~-~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~~~~~~~~~~~~~~~~~~~~p 299 (492)
T PRK10459 223 NYLNTNIDTILIGRILGA-EVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDTEKLRVGFLKLLSVLGIINFP 299 (492)
T ss_pred HHHHhcCchhhhhHhhch-HhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999998887654 589999999999987654 4556788999999885 578889999999999999999999
Q ss_pred HHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhh
Q 015819 352 VSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQG 395 (399)
Q Consensus 352 ~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~ 395 (399)
+.+++..+++++..++.+|+ +..+.+.++++++..++.+...
T Consensus 300 ~~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~ 341 (492)
T PRK10459 300 LLLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGN 341 (492)
T ss_pred HHHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHH
Confidence 99999999999888765544 5567788888887777665544
No 20
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.88 E-value=7.2e-20 Score=178.50 Aligned_cols=206 Identities=14% Similarity=0.136 Sum_probs=187.2
Q ss_pred hHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchh
Q 015819 31 LSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQ 110 (399)
Q Consensus 31 ~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~ 110 (399)
.++..|++++.+.|..+++....+...+|+.+.+.+|++++++|+.+.++.+++...+..+++.+..|.+++++|++|+|
T Consensus 218 ~~~~~k~~l~~~~p~~~~~~~~~~~~~id~~~~~~~~~~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~ 297 (502)
T TIGR01695 218 RDPGLKRFLKLFLPTTLGSSASQITLLINTALASFLEIGSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWN 297 (502)
T ss_pred CChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHH
Confidence 45788999999999999999999999999988666799999999999999988633467899999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCC----ChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchh
Q 015819 111 RIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQ----DPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLII 185 (399)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~ 185 (399)
++++..+++......++++.+++ +.+++++..++.+ |++..+.+..+++++++..++..+..+..+.+++.||++
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~ 377 (502)
T TIGR01695 298 ELRDLLNQGIRLSLLLTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTR 377 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCc
Confidence 99999999999999999999988 8999999998865 556788889999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 186 PMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 186 ~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
.+++.++.+.++|++++++++.. +|+.|+++|+.+++.+..+...++.+|+
T Consensus 378 ~~~~~~~~~~~i~i~l~~~l~~~--~G~~G~~~a~~i~~~~~~~~~~~~~~~~ 428 (502)
T TIGR01695 378 TPFINSVISVVLNALLSLLLIFP--LGLVGIALATSAASMVSSVLLYLMLNRR 428 (502)
T ss_pred cCHHHHHHHHHHHHHHHHHHHHH--HhhhHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999998744 8999999999999999998887777654
No 21
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.86 E-value=1.8e-18 Score=167.62 Aligned_cols=343 Identities=15% Similarity=0.157 Sum_probs=256.1
Q ss_pred HHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 33 GEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 33 ~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
+..++..|-+.....+++...+..++....++|+ |+++.|.++.+.++.++.......|+..+....++++.++++++.
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lar~lg~~~~G~~~~~~~~~~~~~~i~~~G~~~ai~r~ia~~~~~~~~~~ 82 (480)
T COG2244 3 SLKKKLIKGALWLLLGTLISALLGLITIPLLARLLGPEGFGLYALALAIIGLFSILADFGLPAAITREIAEYREKGEYLL 82 (480)
T ss_pred hHHHHHHhhchHHHHHHHHHHHHHHHHHHHHHHHhCcccceeeehHHHHHHHHHHHHHcCCcHHHHHHHHHhhcccHHHH
Confidence 4567888999999999999999999999999995 999999999999999988555568999999999999876666555
Q ss_pred HHHH-HHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHH
Q 015819 112 IGTQ-TYTAIFCLFLVCFPLSFLWIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLS 190 (399)
Q Consensus 112 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 190 (399)
.+.. ...........+++.........+. ++ .....+++..+..+.........+.+|+.++.+.....
T Consensus 83 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~------~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (480)
T COG2244 83 LILLSVLLLLLLALILLLLLLLIAYLLAPI------DP----VLALLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALS 152 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhccc------Ch----hhHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhH
Confidence 5555 4444444444443333332222222 22 22345678889999999999999999999999888887
Q ss_pred HHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHh-cccccccCCCCChHHHhcHHHHHHHHhHHHHH
Q 015819 191 SCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKF-STACAESRVPISMELFQGIGEFFHFAIPSAVM 269 (399)
Q Consensus 191 ~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 269 (399)
.+.. ..-......+.. .......++...+..........+..+ +++..+... +..++..++++++++|....
T Consensus 153 ~~~~-~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~~p~~~~ 225 (480)
T COG2244 153 IVSS-IFLLAAVFALLF---AALGLAVWALVLGAVVSLLVLLILLGKKKRGLKRPIL---RFSLALLKELLRFGLPLLLS 225 (480)
T ss_pred HHHH-HHHHHHHHHHHH---HhhhHHHHHHHHHHHHHHHHHHHHHHHhhhhcccccc---CchhHHHHHHHHHhhHHHHH
Confidence 4333 122222222221 234556666666666666555555542 221111111 11357789999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHH
Q 015819 270 ICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTET 349 (399)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~ 349 (399)
+....+....|.++++.+.++ .++|.|+.++++......+..+++++..|.+++...++|.++.++..+...++...++
T Consensus 226 ~~~~~l~~~~D~~~i~~~l~~-~~vG~Y~~a~~i~~~~~~~~~~l~~~l~P~~s~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (480)
T COG2244 226 SLLNFLFTNIDTLLLGLFLGP-AQVGIYSAAQRLVSLLLIVASALNRVLFPALSRAYAEGDRKALKKLLRQSLKLLLLIS 304 (480)
T ss_pred HHHHHHHHHHHHHHHHHHhhh-hHheecccccHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999988664 5899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhh
Q 015819 350 IVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQG 395 (399)
Q Consensus 350 ~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~ 395 (399)
++..+++..+++++..++.+++. ..+...+.++++...+.++..
T Consensus 305 ~p~~~~l~~~~~~~i~~~fg~~~--~~~~~~l~il~~~~~~~~~~~ 348 (480)
T COG2244 305 IPALLGLLLLAPPIITLLFGEKY--ASAAPILQLLALAGLFLSLVS 348 (480)
T ss_pred HHHHHHHHHHHhhhheeecCCcc--cchhHHHHHHHHHHHHHHHHH
Confidence 99999999999998887654432 225666666666665555544
No 22
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=99.84 E-value=1.8e-18 Score=164.63 Aligned_cols=199 Identities=21% Similarity=0.187 Sum_probs=169.9
Q ss_pred HHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHH
Q 015819 33 GEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRI 112 (399)
Q Consensus 33 ~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~ 112 (399)
+..|+++|.+.|..+++........+.+.+++++|++++++++++.++.++. ..+..|++.|.++.++|++|++|+|++
T Consensus 229 ~~~~~il~ig~P~~~~~~~~~~~~~~~~~~~~~~G~~alAa~~I~~~i~~~~-~~~~~gl~~a~~~lvg~~~Ga~~~~~a 307 (441)
T PRK10367 229 GNFRRLLALNRDIMLRSLLLQLCFGAITVLGARLGSDIIAVNAVLMTLLTFT-AYALDGFAYAVEAHSGQAYGARDGSQL 307 (441)
T ss_pred HHHHHHHHhCchHHHHHHHHHHHHHHHHHHHHhcCHHHHHHHHHHHHHHHHH-HHHHHhHHHHHHHHHHHHHcCCCHHHH
Confidence 5789999999999999999999999999999999999999999999999997 899999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCc---hhHHH
Q 015819 113 GTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSL---IIPMF 188 (399)
Q Consensus 113 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~---~~~~~ 188 (399)
++..+.+..++...+.+++++ +.+++++..+|.+|+|+.+.+..++++.++..+.......+.+.+++.+| ++.++
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~g~lrg~dt~~~~ 387 (441)
T PRK10367 308 LDVWRAACRQSGIVALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCYLLDGMFIGATRAAEMRNSM 387 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccchHHHHHHH
Confidence 999999999999999999988 88999999999999999999999999988764433344455555555554 88888
Q ss_pred HHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 189 LSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 189 ~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
+.+..+..+ ..+.. +++|..|+|++..+++.+..+.+.+.++++
T Consensus 388 ~~~~~~~~~----~~~~~--~~~g~~Gvw~a~~~~~~~~~i~~~~~~~~~ 431 (441)
T PRK10367 388 AVAAAGFAL----TLLTL--PWLGNHGLWLALTVFLALRGLSLAAIWRRH 431 (441)
T ss_pred HHHHHHHHH----HHHHH--HHcCchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 877666332 11122 357999999999999999998887765544
No 23
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.82 E-value=4.8e-17 Score=155.09 Aligned_cols=205 Identities=17% Similarity=0.129 Sum_probs=191.2
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
.+..|++++...|.+++....++...+|+.+.+++++..+++++.|+++.+++...+..++++...|..++...++|.++
T Consensus 194 ~~~~~~~~~~~~p~~l~~~~~qi~~lv~~~laS~l~~G~vs~l~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~~ 273 (451)
T PF03023_consen 194 DPNLKRFLKLAIPLLLSSSISQINILVDRALASFLGEGSVSALNYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWEE 273 (451)
T ss_pred ChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHH
Confidence 56799999999999999999999999999999999999999999999999998667788999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcC----CChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhH
Q 015819 112 IGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIG----QDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIP 186 (399)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 186 (399)
.++..++.+.....+.+|.++. +.+++++.+++. -|++-.+.....+++++++.+++.+...+...+.+.+|++.
T Consensus 274 ~~~~~~~~l~~~~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~~~ 353 (451)
T PF03023_consen 274 FRKTLRKALRLILLILIPASIGLIVLAEPIVRLLFERGAFTAEDTQLTASALRIYALGLPFYALNDLLSRVFYALGDTKT 353 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCcHh
Confidence 9999999999999999999988 999999999874 25566778889999999999999999999999999999999
Q ss_pred HHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 187 MFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 187 ~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
++..++.+.++|++++.++... +|..|.++|+.++..+..+...+.++|+
T Consensus 354 ~~~~~~~~~~lni~l~~~l~~~--~g~~Glala~sl~~~i~~~~l~~~l~r~ 403 (451)
T PF03023_consen 354 PVRISVISVVLNIILSILLVPF--FGVAGLALATSLSAIISALLLYILLRRR 403 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999888855 9999999999999999999998888776
No 24
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.80 E-value=2.2e-17 Score=160.43 Aligned_cols=204 Identities=16% Similarity=0.136 Sum_probs=177.5
Q ss_pred hhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-Ch------h---HHHHH-HHHHHHHHHHHHHHHHHHHHhHHH
Q 015819 30 VLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQ------L---ALSST-AMAISLASVTGFSVLLGMASALET 98 (399)
Q Consensus 30 ~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~------~---~~~~~-~~a~~i~~~~~~~~~~gl~~a~~~ 98 (399)
..++.+|+++++++|.+++++...+...+|+.+++++ ++ + .+|.+ +++.++.+++ ..+..+++.+..|
T Consensus 219 ~~~~~~k~l~~~~~p~~l~~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~-~~~~~~l~~~~~p 297 (488)
T TIGR02900 219 EGKALLFDLFSVSLPLTLSRFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFP-AVITSSLSTALVP 297 (488)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhH-HHHHHHHHHHHHH
Confidence 3367899999999999999999999999999999874 22 1 23333 4566777777 6788999999999
Q ss_pred HHHhhhCccchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHH
Q 015819 99 LCGQAYGAQQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRY 177 (399)
Q Consensus 99 ~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 177 (399)
.+++.+|++|+|+.++..++...+...++++.++. ..+++++..++.+++ .+..+++++++..++........+.
T Consensus 298 ~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~----~~~~~l~i~~~~~~~~~~~~~~~~~ 373 (488)
T TIGR02900 298 DISEAMAKKNYSSIEKRINQAIKISLLLGLITTVILLVIPDELGALFYGRP----DAGNFIRVLAPSFPFLYFSAPLQSI 373 (488)
T ss_pred HHHHHHHcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCC----chHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998887 889999999887544 3567899999999999999999999
Q ss_pred HHHcCchhHHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 178 FQSQSLIIPMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 178 l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
+++.||++..++.++.+.++|++++++++..+++|+.|+++++.+++++..+...+..+|.
T Consensus 374 l~~~g~~~~~~~~~~~~~i~~i~l~~~l~~~~~~G~~Gaaia~~i~~~~~~~~~~~~~~~~ 434 (488)
T TIGR02900 374 LQGLGKQKVALRNSLIGAIVKIILLFVLTSIPSINIYGYAITFIITSVLVTILNLAEIKKN 434 (488)
T ss_pred HHhcCcchHHHHHHHHHHHHHHHHHHHHHhccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998755668999999999999999998888777653
No 25
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.79 E-value=2e-15 Score=142.16 Aligned_cols=239 Identities=14% Similarity=0.110 Sum_probs=203.6
Q ss_pred CcchhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhh
Q 015819 25 STTWGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAY 104 (399)
Q Consensus 25 ~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~ 104 (399)
+.+|+.+.+..|++.+...|..++....++...+|+.+.+.+.+..++.+..+.++.+++.-.+..++++...|..|+..
T Consensus 221 ~p~~~~~~~~lk~~~~~~~p~~l~~sisQi~lli~~~iAS~l~~Gsis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~ 300 (518)
T COG0728 221 KPRFGFKDPGLKRFLKLMLPALLGVSISQINLLIDTAIASFLAEGSVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHA 300 (518)
T ss_pred CCCCCCCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHh
Confidence 34444434789999999999999999999999999999999988999999999999999977899999999999999999
Q ss_pred CccchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCC----ChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHH
Q 015819 105 GAQQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQ----DPQISHEVGKFMIWLLPALFAYATMQPLIRYFQ 179 (399)
Q Consensus 105 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~ 179 (399)
.++|.++.++..+.++.++.+..+|.++. ..+++|+.+.+.. +++-.....+.+..++++.+++.+..++...+.
T Consensus 301 ~~~~~~~~~~~l~~~i~l~lll~lP~~~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FY 380 (518)
T COG0728 301 ANGDWPEFLKLLDWGLRLTLLLTLPASAGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFY 380 (518)
T ss_pred hcCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence 99999999999999999999999999988 9999999998732 444456777889999999999999999999999
Q ss_pred HcCchhHHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHH
Q 015819 180 SQSLIIPMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEF 259 (399)
Q Consensus 180 ~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (399)
+.+++|.++++++++.++|+++++.+.. .+|..|.++++.++.++...++++..+|+.... ..+.|.... .
T Consensus 381 Ar~d~ktP~~i~ii~~~~n~~l~~~l~~--~~~~~giala~s~a~~~~~~ll~~~l~k~~~~~------~~~~~~~~~-~ 451 (518)
T COG0728 381 AREDTKTPMKIAIISLVVNILLNLLLIP--PLGHVGLALATSLAAWVNALLLYYLLRKRLVYL------PGRGWGLFL-I 451 (518)
T ss_pred HccCCCcChHHHHHHHHHHHHHHHHHHh--hccchHHHHHHHHHHHHHHHHHHHHHHHhcCCC------ccchhhHHH-H
Confidence 9999999999999999999999977774 488999999999999999988888877763211 122344444 5
Q ss_pred HHHHhHHHHHHHH
Q 015819 260 FHFAIPSAVMICL 272 (399)
Q Consensus 260 ~~~~~p~~~~~~~ 272 (399)
.|..+-.+++...
T Consensus 452 ~k~~l~~~i~~~~ 464 (518)
T COG0728 452 LKLLLASAIMAAA 464 (518)
T ss_pred HHHHHHHHHHHHH
Confidence 5555555554444
No 26
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.78 E-value=1.2e-19 Score=149.38 Aligned_cols=160 Identities=23% Similarity=0.387 Sum_probs=154.9
Q ss_pred HHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHHHHHHHHHHHH
Q 015819 44 PMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIGTQTYTAIFCL 123 (399)
Q Consensus 44 p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~ 123 (399)
|.+++++...+...+|+.+++++|++++++++++.++.++. ..+..|++.|..+.++|++|++|+|++++..+.+..+.
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~~~~a~~~i~~~~~~~~-~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~~ 79 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGPEALAAYGIASSIFSIL-FMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLLS 79 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTTCCCCHCCHHHHHHHHH-HHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCHHHHHHHHHHHHHHHHH-hhhcccccccccceeecccccccccccccccccccccc
Confidence 88999999999999999999999999999999999999997 88999999999999999999999999999999999999
Q ss_pred HHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHH-HhHHHH
Q 015819 124 FLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAAL-CLHIPI 201 (399)
Q Consensus 124 ~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~i~l 201 (399)
..++++.+++ +.+.+++..+++.|+++.+.+.+|+++..++.++..+.....+++++.|+++..++.++.+. ++++++
T Consensus 80 ~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~l 159 (162)
T PF01554_consen 80 LIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINIPL 159 (162)
T ss_dssp HHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHHHH
T ss_pred hhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHHhH
Confidence 9999999988 99999999999999999999999999999999999999999999999999999999999987 999999
Q ss_pred HHH
Q 015819 202 CWS 204 (399)
Q Consensus 202 ~~~ 204 (399)
+|+
T Consensus 160 ~yl 162 (162)
T PF01554_consen 160 AYL 162 (162)
T ss_dssp HHH
T ss_pred HhC
Confidence 875
No 27
>PRK10459 colanic acid exporter; Provisional
Probab=99.78 E-value=2.4e-15 Score=146.20 Aligned_cols=200 Identities=15% Similarity=0.108 Sum_probs=174.7
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchh
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQ 110 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~ 110 (399)
++..|++++++.|.+.+++...+...+|+.+++++ |++++|.|+.+.++.+++...+...++....|..++. ++|.+
T Consensus 203 ~~~~k~ll~~~~~~~~~~~~~~~~~~~d~~~lg~~lg~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~~ 280 (492)
T PRK10459 203 LASVKPNLSFGAWQTAERIINYLNTNIDTILIGRILGAEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDTE 280 (492)
T ss_pred HHHHHHHHhhhHHHHHHHHHHHHHhcCchhhhhHhhchHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCHH
Confidence 57789999999999999999999999999999996 9999999999999998764555566788888999886 56788
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHH
Q 015819 111 RIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFL 189 (399)
Q Consensus 111 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 189 (399)
+.++.+++.......+++|.++. ...+++++.++.+++ ...+...++++++...+..........+++.||++....
T Consensus 281 ~~~~~~~~~~~~~~~~~~p~~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~~ 358 (492)
T PRK10459 281 KLRVGFLKLLSVLGIINFPLLLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSFK 358 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhHH
Confidence 89999999999999999998887 889999998887655 456788999999999999999999999999999999998
Q ss_pred HHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHh
Q 015819 190 SSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKF 237 (399)
Q Consensus 190 ~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~ 237 (399)
.++...+++++..+.+.. .+|+.|+++++.+++.+......++..|
T Consensus 359 ~~~~~~~~~i~~~~~~~~--~~G~~g~a~a~~i~~~~~~~~~~~~~~~ 404 (492)
T PRK10459 359 WNVFKTFLFIPAIVIGGQ--LAGLIGVALGFLLVQIINTILSYFLMIK 404 (492)
T ss_pred HHHHHHHHHHHHHHHHHh--hccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 888888888887777664 4799999999999999988888776744
No 28
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=99.77 E-value=4.3e-15 Score=132.84 Aligned_cols=270 Identities=14% Similarity=0.164 Sum_probs=203.1
Q ss_pred HHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHHHHHH
Q 015819 39 GYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIGTQTY 117 (399)
Q Consensus 39 ~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~~ 117 (399)
+|.+.....+++......++...++.|+ |++++|.++.+..+.++.......|++.+....+++...+ +++.++...
T Consensus 2 ~k~~~~~~~~~~~~~~~~~~~~~il~r~l~~~~~G~~~~~~~~~~~~~~~~~~G~~~~~~r~~~~~~~~--~~~~~~~~~ 79 (273)
T PF01943_consen 2 LKNSLWLFLSNILSALIGFITIPILARYLGPEEYGIYSLALSIVSLLSILADLGLSQAIVRFIAEYKDK--KELRSAYFS 79 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCHHHhHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHhhhh--HHHHHHHHH
Confidence 5667778889999999999999999995 9999999999999999874555889999999888886433 344444444
Q ss_pred HHHHHHHHHHHHHHHHHHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHh
Q 015819 118 TAIFCLFLVCFPLSFLWIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAALCL 197 (399)
Q Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 197 (399)
.......+.+++..+.... ...+..++.. ..+........+..........++++.++.+......+...++
T Consensus 80 ~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (273)
T PF01943_consen 80 SVLFLLLIFSLIFLLILLI----ASFFGNPSLS----LILIILALLILILSSLSSVFSGLLQGLQRFKYIAISNIISSLL 151 (273)
T ss_pred HHHHHHHHHHHHHHHHHHH----HHHcCCchHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4444444433333333222 2233333321 1222222222257788888889999999999999988888888
Q ss_pred HHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHHHHHHHHHH
Q 015819 198 HIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVMICLEWWSF 277 (399)
Q Consensus 198 ~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 277 (399)
..++...++.. +.+..+..++..++.++..+...++.+|+.+ .+....+++..|++++.+.|..+.++...+..
T Consensus 152 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (273)
T PF01943_consen 152 SLLLILLLLFL-GSSLWGFLLGLVISSLVSLIISLFYLRRKLR-----PRFSFFSKKFFKEILRFGLPLFLSSLLSWLYS 225 (273)
T ss_pred HHHHHHHHHHH-hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHc-----ccccccchHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 88777776654 3348889999999999888888777776532 12222225778999999999999999999999
Q ss_pred HHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 015819 278 ELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNE 325 (399)
Q Consensus 278 ~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~ 325 (399)
..+.++++.+.+. +++|.|+++.++......+..+++++..|.+++.
T Consensus 226 ~~d~~ii~~~~g~-~~vg~Y~~a~~l~~~~~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 226 QIDRLIIGYFLGP-EAVGIYSVAYRLASAISFLLSSISTVLFPRLSRL 272 (273)
T ss_pred HhHHHHHHHhCCH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 9999999998764 5899999999999999999999999999999985
No 29
>PRK15099 O-antigen translocase; Provisional
Probab=99.76 E-value=3.9e-16 Score=148.35 Aligned_cols=203 Identities=11% Similarity=0.045 Sum_probs=174.5
Q ss_pred hhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHh-ccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCc
Q 015819 28 WGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVG-HLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGA 106 (399)
Q Consensus 28 ~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~-~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~ 106 (399)
++.+++..|++++++.|..++++...+...+|+.+++ ++|++++|.|+.+.++.+.+...+..+++++..|.+++.
T Consensus 207 ~~~~~~~~k~ll~~g~p~~~~~~~~~i~~~~~~~~l~~~~g~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~--- 283 (416)
T PRK15099 207 PSWDNGLAGQLGKFTLMALITSVTLPVAYVMMRNLLAAHYSWDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL--- 283 (416)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---
Confidence 3344678999999999999999999999999999997 579999999999999987433678999999999999995
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchh
Q 015819 107 QQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLII 185 (399)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~ 185 (399)
+|+|+.++..++.......++++.+++ ++++++++.++.+|+ ++.+.++++++++..++...+..+...+.+.++.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~ 361 (416)
T PRK15099 284 TEKRDITREIVKALKFVLPAVAAASFTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLR 361 (416)
T ss_pred CChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 567888899999998888888888877 799999999998875 34467888998888888877777776666778888
Q ss_pred HHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHh
Q 015819 186 PMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKF 237 (399)
Q Consensus 186 ~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~ 237 (399)
......+...+++++++++++.. +|..|+++++.+++++......+...+
T Consensus 362 ~~~~~~~~~~~l~i~l~~~li~~--~G~~G~a~a~~is~~~~~~~~~~~~~~ 411 (416)
T PRK15099 362 FYILAEVSQFTLLTGFAHWLIPL--HGALGAAQAYMATYIVYFSLCCGVFLL 411 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHH--hhhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 88888888899999999999854 899999999999999999887765554
No 30
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.69 E-value=1.8e-14 Score=139.67 Aligned_cols=190 Identities=16% Similarity=0.180 Sum_probs=173.2
Q ss_pred hhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCc
Q 015819 28 WGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGA 106 (399)
Q Consensus 28 ~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~ 106 (399)
++..++..|++++.++|..++++...+.+.+|+.+++++ |++++|.|+.++++.... ..+...++....|..++...+
T Consensus 205 ~~~~~~~~~~~l~~~~p~~~~~~~~~l~~~~D~~~i~~~l~~~~vG~Y~~a~~i~~~~-~~~~~~l~~~l~P~~s~~~~~ 283 (480)
T COG2244 205 LRFSLALLKELLRFGLPLLLSSLLNFLFTNIDTLLLGLFLGPAQVGIYSAAQRLVSLL-LIVASALNRVLFPALSRAYAE 283 (480)
T ss_pred cCchhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHhhhhHheecccccHHHHHH-HHHHHHHHHHHHHHHHHHHHc
Confidence 333478999999999999999999999999999999996 999999999999998887 889999999999999999999
Q ss_pred cchhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchh
Q 015819 107 QQYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLII 185 (399)
Q Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~ 185 (399)
+|.++.++..++........+++..+. ..+++++...+.+++. ..+...+.++++..++..+.......+++.|+.+
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~i~~~fg~~~--~~~~~~l~il~~~~~~~~~~~~~~~~l~~~g~~~ 361 (480)
T COG2244 284 GDRKALKKLLRQSLKLLLLISIPALLGLLLLAPPIITLLFGEKY--ASAAPILQLLALAGLFLSLVSLTSSLLQALGKQR 361 (480)
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhheeecCCcc--cchhHHHHHHHHHHHHHHHHHHHHHHHHHcCcch
Confidence 999999999999999999999999988 8999999998877653 2377888999999999999999999999999999
Q ss_pred HHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHH
Q 015819 186 PMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGIS 223 (399)
Q Consensus 186 ~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~ 223 (399)
.....+..+.++|++++++++. .+|..|++.++ .+
T Consensus 362 ~~~~~~~~~~i~~~~l~~~li~--~~g~~g~~~a~-~~ 396 (480)
T COG2244 362 LLLLISLISALLNLILNLLLIP--RFGLIGAAIAT-AS 396 (480)
T ss_pred hhHHHHHHHHHHHHHHHhHHHH--hhhhhhHHHHH-HH
Confidence 9999999999999999999984 48999999999 44
No 31
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=99.59 E-value=1.2e-11 Score=109.14 Aligned_cols=246 Identities=17% Similarity=0.217 Sum_probs=173.7
Q ss_pred HHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHHHHHHHHHHHHHHHHHHHHHH
Q 015819 55 LQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIGTQTYTAIFCLFLVCFPLSFL 133 (399)
Q Consensus 55 ~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (399)
.+++...+++|+ |++++|.|+....+.++.......|+...... . .++|+++.++..+.......+.+++..++
T Consensus 3 ~~f~~~~~lar~l~~~~~G~~~~~~s~~~~~~~~~~~g~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 77 (251)
T PF13440_consen 3 INFLFLILLARYLGPEDFGIYALIFSIVSILSIVASLGLRQSLVR----S-AARDKQDIRSLLRFSLLVSLLLAVILAIL 77 (251)
T ss_pred HHHHHHHHHHHHCCHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHH----h-hccCHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 456677788885 99999999999999998744345666655443 2 24555666666666554444443333322
Q ss_pred HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHhHHHHHHHHhhhccCcc
Q 015819 134 WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAALCLHIPICWSLVYKSGLGN 213 (399)
Q Consensus 134 ~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~ 213 (399)
...+..++ .+++ ...++....+..+.........+.+++.+|.+..........+....+..++... +.+.
T Consensus 78 ---~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 148 (251)
T PF13440_consen 78 ---AILIAYFF-GDPE----LFWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLRLLLLVLLLYL-GLNL 148 (251)
T ss_pred ---HHHHHHHh-CChh----HHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHHH-HhhH
Confidence 22222233 3332 2345566777888889999999999999999999888888888775555554443 3478
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHhcccccccCCCCChHHHhcHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCChhHH
Q 015819 214 LGGALAIGISNWLNVTFLAIYMKFSTACAESRVPISMELFQGIGEFFHFAIPSAVMICLEWWSFELLILMSGLLPNPQLE 293 (399)
Q Consensus 214 ~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (399)
.+..++..++.++..+......+++ . +..+ +++..| ..+.+.|..+.+.........+.++++.+.+ .++
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~--~-----~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~-~~~ 218 (251)
T PF13440_consen 149 WSILLAFIISALLALLISFYLLRRK--L-----RLSF-KFSWRR-LLKYGLPFSLSSLLSWLLSQIDRLLIGYFLG-PEA 218 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhccc--c-----CCCc-hhhHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC-HHH
Confidence 8888888888888776665533221 1 1111 122234 7899999999999999999999999998434 468
Q ss_pred HHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHH
Q 015819 294 TSVLSVCLNTIQTLY-AIPYGLGAAVSTRVSN 324 (399)
Q Consensus 294 ~a~~~i~~~i~~~~~-~~~~~i~~a~~~~~~~ 324 (399)
+|.|+++.++..... .+..++++...|.++|
T Consensus 219 ~g~y~~a~~l~~~~~~~~~~~i~~~~~p~lar 250 (251)
T PF13440_consen 219 VGIYSVAQRLASLPASLLSSAISSVFFPKLAR 250 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhC
Confidence 999999999999888 9999999999999986
No 32
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.51 E-value=1.9e-14 Score=118.17 Aligned_cols=133 Identities=21% Similarity=0.355 Sum_probs=126.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHhcCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHHHHHHHHHHHHH
Q 015819 265 PSAVMICLEWWSFELLILMSGLLPNPQLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQKARVAVYAVIFM 344 (399)
Q Consensus 265 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~ 344 (399)
|.+++++.+...+.+++.+++++++ ++++++++..++.++..++..|++++..+.+++++|++|+|++++..+.++.+
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g~--~~~a~~~i~~~~~~~~~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~ 78 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLGP--EALAAYGIASSIFSILFMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLL 78 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCTT--CCCCHCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhCH--HHHHHHHHHHHHHHHHhhhcccccccccceeeccccccccccccccccccccc
Confidence 8899999999999999999999964 48999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 345 AVTETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
...+++++++++..+++++.++|+.|+|+.+.+.+.+++..++.++.+...+.++
T Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 133 (162)
T PF01554_consen 79 SLIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSG 133 (162)
T ss_dssp HHHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCC
T ss_pred chhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999998877653
No 33
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.50 E-value=1.4e-12 Score=120.76 Aligned_cols=131 Identities=21% Similarity=0.320 Sum_probs=122.3
Q ss_pred hhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccch
Q 015819 30 VLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQY 109 (399)
Q Consensus 30 ~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~ 109 (399)
..++..|+++++++|.++.++...+...+|+.+++++|++++++|+.+.++.++. ..+..+++.+..|.+++++|++|.
T Consensus 210 ~~~~~~k~~~~~~~P~~~~~l~~~~~~~~~~~i~~~~g~~~v~~~~~a~~~~~~~-~~~~~~~~~a~~~~~~~~~~~~~~ 288 (342)
T TIGR00797 210 PDWEVLKRLLKLGLPIAFRVILESLSFALLALLVARLGSIALAAHQIALNVESLL-FMPAFGFGIAVSILVGQALGAGDP 288 (342)
T ss_pred CCHHHHHHHHHhCchHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhCCCCH
Confidence 3467899999999999999999999999999999999999999999999999987 889999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHH
Q 015819 110 QRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWL 161 (399)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~ 161 (399)
|+.++..+++......++++.+++ .++++++.+++.+|+++.+.+..++++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T TIGR00797 289 KRAKEVARVALKLSLLLGLVLAIILILFREFIARLFTNDPEVLELAAIYLIFV 341 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHh
Confidence 999999999999999999998887 8899999999999999999988887664
No 34
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.15 E-value=1.5e-10 Score=110.01 Aligned_cols=208 Identities=13% Similarity=0.090 Sum_probs=183.5
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhccC--hhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccch
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLG--QLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQY 109 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g--~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~ 109 (399)
.+.+++++++++|..+...++.-...+-....|.++ ..++++.++...+.... .....|++.+.++.+++.+|++|.
T Consensus 243 ~~~~~~~~~lai~s~~miclE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~-~~~~~~~~~a~strv~neLGag~p 321 (473)
T KOG1347|consen 243 FDSWGPFFALAIPSAVMICLEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWH-LMIPGAFSAAVSTRVSNELGAGKP 321 (473)
T ss_pred hhhHHHHHHHhhcchheeHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHH-HHHhhhhhhhHHHHHHHHHcCCCh
Confidence 678899999999999999999999999999999985 46899999999998887 788899999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHH
Q 015819 110 QRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMF 188 (399)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 188 (399)
+++|.....+...+...+...+.. +.+.+.+...|..|+++.+...+..++++++......+.+..+..++.|+.+...
T Consensus 322 ~~ar~~~~v~~~~~~~~g~~~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~Gva~g~g~q~~ga 401 (473)
T KOG1347|consen 322 KRARVSAKVALQTSVAIGASLGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSGVARGSGWQQIGA 401 (473)
T ss_pred hhhhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhheEEeeccccceE
Confidence 999999999999988889888877 8888899999999999999999999999999999999999999999999988887
Q ss_pred HHHHHH-HHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhccc
Q 015819 189 LSSCAA-LCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTA 240 (399)
Q Consensus 189 ~~~~~~-~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~ 240 (399)
+.++.. .++.+++...+-+..++|..|.|++...+..+....+.....+.+|
T Consensus 402 ~vnl~~yyl~G~p~g~~l~~~~~~g~~glw~G~~~~~~~~~~~l~~~~~~tdW 454 (473)
T KOG1347|consen 402 VINLVAYYLVGAPVGLYLGFFTKFGVKGLWIGILLGFSVQTLVLAIVTARTDW 454 (473)
T ss_pred EEeeeeeeEecCcceeEEEEEEecCceEEEeehHHHHHHHHHHHHHheeeccH
Confidence 776655 5666677777666678999999999999977777777666655544
No 35
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=99.02 E-value=2.6e-06 Score=74.35 Aligned_cols=316 Identities=13% Similarity=0.036 Sum_probs=186.2
Q ss_pred HHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-c-Ch-hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccch
Q 015819 33 GEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGH-L-GQ-LALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQY 109 (399)
Q Consensus 33 ~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~-~-g~-~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~ 109 (399)
...++++++-+|..++++...+.-.+.+.-++| - .+ +.+++|++|..+.-++ ..+...+-.....++-+ ++
T Consensus 8 ~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~-~sp~~~~~~igl~~V~s-----~r 81 (345)
T PF07260_consen 8 TSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFF-ASPLSMFHHIGLVFVNS-----KR 81 (345)
T ss_pred chHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHH-hChhhhhHHHHHHHhcc-----hh
Confidence 467899999999999999999998888888887 3 33 5699999999998887 66777666665554443 22
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHH--HHhHHHHH-HHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhH
Q 015819 110 QRIGTQTYTAIFCLFLVCFPLSFL--WIYAGKLL-VLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIP 186 (399)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~i~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 186 (399)
++ ++........+.+...+..++ -.....++ ..++.++++.+.+...+.++.+-.++..+....++++--.++...
T Consensus 82 sr-r~~vl~~~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~s~i 160 (345)
T PF07260_consen 82 SR-RKAVLCMAVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRHSWI 160 (345)
T ss_pred hh-HHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhccceeE
Confidence 22 122222222222222222222 23344444 456789999999999999999999999999999998886677777
Q ss_pred HHHHHHHHHHhHHHHHHHHhhhccCcc-chhH---HHHHHHHHHHHHH-HHHHHHhcccccccCCCCChHHHhcHHHHHH
Q 015819 187 MFLSSCAALCLHIPICWSLVYKSGLGN-LGGA---LAIGISNWLNVTF-LAIYMKFSTACAESRVPISMELFQGIGEFFH 261 (399)
Q Consensus 187 ~~~~~~~~~~~~i~l~~~li~~~~~g~-~G~~---~a~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (399)
....++...+..+++...++.. ++.. +... ++...+..+.... ++-++.+-....+.......++...++++++
T Consensus 161 V~~aSI~~v~~qvV~v~~ll~~-~l~~~~pllipil~~y~g~~vr~t~v~LGy~~~i~~~~p~~~~~~~~~~~tl~~~l~ 239 (345)
T PF07260_consen 161 VGSASIADVIAQVVLVAILLSM-HLEPQDPLLIPILALYAGIAVRFTIVCLGYYQSIHDIIPQLSGLEKGDSATLQRMLK 239 (345)
T ss_pred eehHHHHHHHHHHHHHHHHHcc-ccCccccHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhccccCCcccCCChhHHHHHH
Confidence 7676666666666655555532 1111 2222 2222222222211 1112211111111121222223356889999
Q ss_pred HHhHHHHHHHHHHHHHHHHHHHHhc-CCCh---hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChHH----
Q 015819 262 FAIPSAVMICLEWWSFELLILMSGL-LPNP---QLETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQK---- 333 (399)
Q Consensus 262 ~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~---- 333 (399)
+.+|.+.....+..+--+.+..+++ +++. .++++.-.+.+...-+.+-..+-+. +..|..-+.-..++..+
T Consensus 240 F~~PL~~~~~tq~~SrplVnl~vsR~l~gs~a~~~avavl~~~ypvgh~~y~w~~~~r-~~~paf~~~~~~~~~~~~~~~ 318 (345)
T PF07260_consen 240 FWWPLALVLATQRISRPLVNLFVSRDLSGSQAATEAVAVLTATYPVGHMPYGWLTELR-AVYPAFDKNNPQNKLRNCGNP 318 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhccCCcccchhhhhhhccccCCCcCcchhHHhHH-hhCchhhccCcccccccccCc
Confidence 9999999999999999999999998 4432 2355555555554444443332221 23333322211111111
Q ss_pred -HHHHHHHHHHHHHHHHHHHHHHHH
Q 015819 334 -ARVAVYAVIFMAVTETIVVSATLF 357 (399)
Q Consensus 334 -~~~~~~~~~~~~~~~~~~~~~~~~ 357 (399)
.+...++....++.+++.+++.++
T Consensus 319 v~~~~~~kf~~~c~~~sl~~~f~~f 343 (345)
T PF07260_consen 319 VTQSHISKFVVLCLLLSLALCFVMF 343 (345)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHh
Confidence 123556666666666666665543
No 36
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.73 E-value=2.4e-06 Score=82.81 Aligned_cols=203 Identities=11% Similarity=0.031 Sum_probs=164.5
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc--c-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccch--
Q 015819 35 VKKQGYIAAPMVAVTLSQYLLQVVSMMMVGH--L-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQY-- 109 (399)
Q Consensus 35 ~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~--~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~-- 109 (399)
-++.++.....+.++++..+.+--|.+++.. + +.++-|.|+++.++.++.+=.+...+-.+.-.+.++...+++.
T Consensus 252 d~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~l~~~~~~~ 331 (549)
T PF04506_consen 252 DRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTFEDQGVYALVSNYGSLVARLLFQPIEESSRLYFSKLLSRDNSKK 331 (549)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCHHHhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHHhcccCchh
Confidence 4788889999999999999999999999999 6 8899999999999999887788889999999999988765433
Q ss_pred -------hHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHc
Q 015819 110 -------QRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQ 181 (399)
Q Consensus 110 -------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~ 181 (399)
++..+.....+.+...+++++.+. ....+.++.++++++...+.+...++.++...|+.+++.+.-++.++.
T Consensus 332 ~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi~EaF~~s~ 411 (549)
T PF04506_consen 332 KQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGITEAFVFSV 411 (549)
T ss_pred hccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccHHHHHHHHh
Confidence 335556666677777777776666 777788888876655444556788999999999999999999988865
Q ss_pred Cc---hhHHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 182 SL---IIPMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 182 ~~---~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
.. .+..........++.+..+++++.. ++|..|..+|..+...+..+.+..+.++.
T Consensus 412 a~~~~l~~~~~~m~~~S~~f~~~~~~l~~~-~~G~~GlI~AN~iNM~lRI~ys~~fI~~~ 470 (549)
T PF04506_consen 412 ASESQLDRYNYWMVVFSAIFLAASYLLTRW-GLGAVGLILANCINMSLRIIYSLRFIRRY 470 (549)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 43 3333344555667778888998876 79999999999999999999998888764
No 37
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=98.57 E-value=1.1e-05 Score=64.69 Aligned_cols=79 Identities=20% Similarity=0.235 Sum_probs=73.3
Q ss_pred HHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHh
Q 015819 158 MIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKF 237 (399)
Q Consensus 158 l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~ 237 (399)
+++++++.++..+.....+.+++.||++.....++.+.++|+++++.++ +++|..|+++|+.+++.+......+..+|
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li--~~~G~~Gaa~a~~i~~~~~~~~~~~~~~k 79 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILI--PRFGIYGAAIATAISEIVSFILNLWYVRK 79 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHH--HHHHHhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999999999999999999999999999999999999997 45999999999999999999888888776
Q ss_pred c
Q 015819 238 S 238 (399)
Q Consensus 238 ~ 238 (399)
+
T Consensus 80 ~ 80 (146)
T PF14667_consen 80 K 80 (146)
T ss_pred H
Confidence 5
No 38
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.56 E-value=4.3e-05 Score=74.23 Aligned_cols=356 Identities=12% Similarity=0.014 Sum_probs=190.2
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHH--HHHHHHHHHHHHhHHHHHHhhhCccchhHHHHHHH
Q 015819 41 IAAPMVAVTLSQYLLQVVSMMMVGH-LGQLALSSTAMAISLAS--VTGFSVLLGMASALETLCGQAYGAQQYQRIGTQTY 117 (399)
Q Consensus 41 ~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~~~~~~a~~i~~--~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~~ 117 (399)
-+--.++.+++..+.+++-+.++-| .+++.+|..++=..+.. ++ +.--.++-.|.+..-.+...++|.++..+..+
T Consensus 6 gas~li~lQl~sRllTFvlN~lllR~lsp~ilGi~nv~LeLl~sTIL-FlSRE~fR~A~lR~~~~~~~~~~~~~~~n~~w 84 (549)
T PF04506_consen 6 GASFLILLQLLSRLLTFVLNQLLLRFLSPEILGIANVQLELLYSTIL-FLSREAFRRACLRQPSSSIDKSNWAQSINLLW 84 (549)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHhCCHHHhhhHHHHHHHHHHHHH-HHHHHHHHHHHhcCCCcccCcccHHHhhhccc
Confidence 3445677788888888887777777 49999888754444332 22 45566888887765544422233334444333
Q ss_pred HHHHHHHHHHHHHHHH-H-HhHHH----HHHHcCC-Chh---HHHHHHHHHHHHHhHHHHHHHHHHHHHHHHH----cCc
Q 015819 118 TAIFCLFLVCFPLSFL-W-IYAGK----LLVLIGQ-DPQ---ISHEVGKFMIWLLPALFAYATMQPLIRYFQS----QSL 183 (399)
Q Consensus 118 ~~~~~~~~~~~~~~~~-~-~~~~~----i~~~~~~-~~~---~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~----~~~ 183 (399)
....+..+...+++.+ + ....+ ...+... .++ ..+.....+.+...+.....+...+-...|. .-|
T Consensus 85 ls~~lq~vvn~~~~~I~l~~igi~~~~~~~~~~~~~~~~~~~~~p~~~~~v~l~~~s~~iELlsEP~~il~Q~~l~~~~R 164 (549)
T PF04506_consen 85 LSVPLQAVVNLICSYIWLAWIGIPLSILLSQYQYASISNAFVIEPYFEPSVFLYGLSAFIELLSEPLYILAQQMLFFKLR 164 (549)
T ss_pred ccCcchhheehhHHHHhHhhccccHHHHHHHHHhhcchhhHHhhhhHHHHHHHHHHHHHHHHhhhHHHHHHHHHhhhhee
Confidence 3333333333322222 1 11111 1111111 111 1112222334445555555555554333333 234
Q ss_pred hhHHHHHHHHHHHhHHHHHHHHhhh-ccCcc-----ch-hHHHHHHHHHHHHHHHHHHHHhc--cc---ccccCCCCCh-
Q 015819 184 IIPMFLSSCAALCLHIPICWSLVYK-SGLGN-----LG-GALAIGISNWLNVTFLAIYMKFS--TA---CAESRVPISM- 250 (399)
Q Consensus 184 ~~~~~~~~~~~~~~~i~l~~~li~~-~~~g~-----~G-~~~a~~i~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~- 250 (399)
.+.-........+++..+....... .+++. .+ +.++..++++...+......... .. ......+...
T Consensus 165 v~~E~~A~~~k~i~t~~~v~~~~~~~~~~~~~~~~~~~~~~l~Falgq~~ys~~l~~~y~~~~~~~~~~~s~~lp~i~~~ 244 (549)
T PF04506_consen 165 VKAESLAVFAKCIVTFALVVLAERSGYGFFYFLSGQEGLAILAFALGQLAYSITLFFCYYWMYFFPFKSFSDLLPKISSG 244 (549)
T ss_pred eEechHHHHHHHHHHHHHHHHHHhcccceeeeeccchhHHHHHHHHHHHHHHHHHHhhHHhhccCcccchhhcccccccc
Confidence 4444444444444444443333211 01111 11 24455555555443332221111 11 0011111111
Q ss_pred --HHHhcHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhc--CCChhHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHH
Q 015819 251 --ELFQGIGEFFHFAIPSAVMICLEWWSFELLILMSGL--LPNPQLETSVLSVCLNTIQTLY-AIPYGLGAAVSTRVSNE 325 (399)
Q Consensus 251 --~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~a~~~i~~~i~~~~~-~~~~~i~~a~~~~~~~~ 325 (399)
+....-+++.+.......+++.-.+..+-+.+++.. +.+. ++-|.|.+++++-+++. ++..-+-.+.....++.
T Consensus 245 ~~~~~~fd~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~t~-~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~ 323 (549)
T PF04506_consen 245 NPKSYYFDRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLLTF-EDQGVYALVSNYGSLVARLLFQPIEESSRLYFSKL 323 (549)
T ss_pred ccccccCCHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccCCH-HHhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHH
Confidence 011123678888999999999998889988888888 6654 47799999999987765 55567888888888888
Q ss_pred hcCCChH---------HHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhh
Q 015819 326 LGAGNVQ---------KARVAVYAVIFMAVTETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGV 396 (399)
Q Consensus 326 ~g~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v 396 (399)
...++.+ +..+.....++....++++....-...++.+.+++.++.-........++.++...++.++|++
T Consensus 324 l~~~~~~~~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi 403 (549)
T PF04506_consen 324 LSRDNSKKKQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGI 403 (549)
T ss_pred hcccCchhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccH
Confidence 7655432 3444455555555555555554445555556666644333333458889999999999999987
Q ss_pred cc
Q 015819 397 FS 398 (399)
Q Consensus 397 ~~ 398 (399)
..
T Consensus 404 ~E 405 (549)
T PF04506_consen 404 TE 405 (549)
T ss_pred HH
Confidence 64
No 39
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=98.42 E-value=2.3e-05 Score=71.56 Aligned_cols=201 Identities=9% Similarity=0.008 Sum_probs=151.5
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc---ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHH
Q 015819 36 KKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL---GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRI 112 (399)
Q Consensus 36 ~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~---g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~ 112 (399)
++..+.......+.+..++.+--|.+++.-+ +-++-|.|.+..+..++.+=.+...+--..-.+.+|....+++|+.
T Consensus 239 ~d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~~ 318 (530)
T KOG2864|consen 239 NDLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQENV 318 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhhH
Confidence 5566666677888899999999999998843 6667888999999888887778888888888899998887777766
Q ss_pred HHHHH---HHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhH--
Q 015819 113 GTQTY---TAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIP-- 186 (399)
Q Consensus 113 ~~~~~---~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~-- 186 (399)
++... ..+.....+++.+... ....+..+.+.+++......+...+++++...|+.+++.+.-++..+.+..+-
T Consensus 319 k~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~t~~qi~ 398 (530)
T KOG2864|consen 319 KKAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVATSRQID 398 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhccHHHHH
Confidence 66554 4455555566555544 56667777777665544445567889999999999999999998886543221
Q ss_pred -HHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhc
Q 015819 187 -MFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFS 238 (399)
Q Consensus 187 -~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~ 238 (399)
.-.......+..++++++++.+ +|..|..+|.++...+..+....+.++.
T Consensus 399 ~~n~~mlafSviflilsylL~~~--~~~~GlIlANiiNm~lRIlys~~fI~~~ 449 (530)
T KOG2864|consen 399 KHNKFMLAFSVIFLILSYLLIRW--FGLVGLILANIINMSLRILYSLRFIRHY 449 (530)
T ss_pred hcccchhHHHHHHHHHHHHHHHH--hchhHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 1223345567778899999987 7789999999999999988887776654
No 40
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=98.14 E-value=0.0066 Score=56.05 Aligned_cols=357 Identities=11% Similarity=-0.008 Sum_probs=182.7
Q ss_pred HHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHH--HHHHHHHHHHHHhHHHHHHhhhCccchhH
Q 015819 35 VKKQGYIAAPMVAVTLSQYLLQVVSMMMVGH-LGQLALSSTAMAISLAS--VTGFSVLLGMASALETLCGQAYGAQQYQR 111 (399)
Q Consensus 35 ~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~~~~~~a~~i~~--~~~~~~~~gl~~a~~~~~s~~~g~~~~~~ 111 (399)
.....+-+.-.+..++...+.++.-+..+-| .+++.+|..++=..+.+ ++ +.---++.-|..+.-++. +++.++
T Consensus 7 L~ss~~ga~~~i~~Q~~~RiiTF~lN~~liR~~s~~v~gi~nvrl~lL~sTiL-FlsREair~A~l~~gs~~--~d~~te 83 (530)
T KOG2864|consen 7 LESSFSGAVFSIRGQLLARIITFALNALLIRFLSPEVLGIVNVRLELLQSTIL-FLSREAIRLAELRIGSEP--ADTWTE 83 (530)
T ss_pred HHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHcChhheehhHHHHHHHHHHHH-HhhHHHHHHHhccCCCCC--CccHHH
Confidence 3444555555666677776666665555555 69999998877665544 22 334456666655444442 233445
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCChh-HHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHH
Q 015819 112 IGTQTYTAIFCLFLVCFPLSFLWIYAGKLLVLIGQDPQ-ISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLS 190 (399)
Q Consensus 112 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 190 (399)
..+..+.+-.+..+..+++.-+++.-..- .|+. ..+.-...+.+...+...-.+...+.-..|..-+.+...+.
T Consensus 84 ~~n~~wlS~~L~~~i~~~~i~~wl~~~~s-----~d~i~~~p~y~~~I~~~~~S~vvELlsEp~~iv~Q~~~~~~~~~i~ 158 (530)
T KOG2864|consen 84 FINLLWLSVPLQTAINVACIYFWLGFLSS-----SDEISYSPLYAFAIFIIGLSIVVELLSEPLYIVSQCGLKVQLRAIA 158 (530)
T ss_pred HHHhhhhhhhHHHHHHHHHHHHHHHHhhc-----cchhhcCchHhHHHHHHHHHHHHHHhcccHHHHHHHHHHHHHHHHH
Confidence 55555555555544444433222111111 1111 11111222334445555555555555555555555555555
Q ss_pred HHHHHHhH-HHHHHHHhhhc-cCccchhHHHHHHHHHHHHH-HHHHHHHhcccccc---------cCCCCChH--HHhcH
Q 015819 191 SCAALCLH-IPICWSLVYKS-GLGNLGGALAIGISNWLNVT-FLAIYMKFSTACAE---------SRVPISME--LFQGI 256 (399)
Q Consensus 191 ~~~~~~~~-i~l~~~li~~~-~~g~~G~~~a~~i~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~--~~~~~ 256 (399)
.....++. +.....++.++ ++++.--++|.....+...+ ....+++.++.... ..++.... ....-
T Consensus 159 e~l~~~v~~i~~fa~lv~~~~~~~l~~FAlaql~~~itl~l~y~~~Yf~~~~s~~~~~~~~r~Sdllpk~~~n~~~~ffd 238 (530)
T KOG2864|consen 159 EGLATIVKCIVLFAGLVMGPNMYALLAFALAQLAYAITLLLCYYWFYFYIRGSIPETEPFSRFSDLLPKVSENERGIFFD 238 (530)
T ss_pred hHHHHHHHHHHHHHHHHhcCchhHHHHHHHHHHHhhHHHHHHHHHHHHHHcCCcccccchhhhhhhccCCCCCCcccccc
Confidence 55665555 33333333332 34455555555555444444 12222333320000 00010000 00111
Q ss_pred HHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCCh-hHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhcCCChHHH
Q 015819 257 GEFFHFAIPSAVMICLEWWSFELLILMSGLLPNP-QLETSVLSVCLNTIQTLY-AIPYGLGAAVSTRVSNELGAGNVQKA 334 (399)
Q Consensus 257 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~a~~~i~~~i~~~~~-~~~~~i~~a~~~~~~~~~g~~~~~~~ 334 (399)
++..+.-.....+...-.+...-+..++.....- -.+-|.|..+++.-++.. ++..-+-...-...+|....++.|+.
T Consensus 239 ~d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLlaR~iF~PIEEss~~~FA~~ls~~~qe~~ 318 (530)
T KOG2864|consen 239 NDLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLARLIFRPIEESSYIYFARLLSRDNQENV 318 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHHHHHhChhHHHHHHHHHHHhhccchhhH
Confidence 2444555555555555555555555555432110 114567888887776655 55667888888888888888888877
Q ss_pred HHHHHHHHHHHH---HHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 335 RVAVYAVIFMAV---TETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 335 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
|+.......+.- .+++.....-...++....+++++.-.-..+...++++++..++.+++++..|
T Consensus 319 k~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEa 386 (530)
T KOG2864|consen 319 KKAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEA 386 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHH
Confidence 766554443333 33322222223344456666654333233455889999999999999988653
No 41
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=97.70 E-value=0.00031 Score=62.40 Aligned_cols=71 Identities=18% Similarity=0.213 Sum_probs=67.2
Q ss_pred HHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhh
Q 015819 32 SGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLASVTGFSVLLGMASALETLCGQA 103 (399)
Q Consensus 32 ~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~ 103 (399)
++..|++++.+.|..++++...+....|+.+++++ |++++|.|+.+.++.... ..+...+.+...|.+++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ii~~~~g~~~vg~Y~~a~~l~~~~-~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 201 KKFFKEILRFGLPLFLSSLLSWLYSQIDRLIIGYFLGPEAVGIYSVAYRLASAI-SFLLSSISTVLFPRLSRL 272 (273)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhCCHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHh
Confidence 68899999999999999999999999999999997 999999999999999998 788999999999999885
No 42
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=97.41 E-value=0.0098 Score=52.53 Aligned_cols=139 Identities=9% Similarity=0.002 Sum_probs=99.5
Q ss_pred hcHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCChh-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCChH
Q 015819 254 QGIGEFFHFAIPSAVMICLEWWSFELLILMSGLLPNPQ-LETSVLSVCLNTIQTLYAIPYGLGAAVSTRVSNELGAGNVQ 332 (399)
Q Consensus 254 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~a~~~i~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~ 332 (399)
..++++.++.+|.++++....++..+.+--+++-.+++ +.+|+|+.+..+.-++..+...+.+.....+.+. .+
T Consensus 8 ~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~~sp~~~~~~igl~~V~s~-----rs 82 (345)
T PF07260_consen 8 TSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFFASPLSMFHHIGLVFVNSK-----RS 82 (345)
T ss_pred chHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHHhChhhhhHHHHHHHhcch-----hh
Confidence 45778999999999999999999999987777643333 4599999999999999999988888777776432 22
Q ss_pred HHHHHHHHHHHHHHHHHH-H-HHHHHHhhhhhh-hccccCchhHHHHHHHHHHHHHHHHHHhhhhhhccC
Q 015819 333 KARVAVYAVIFMAVTETI-V-VSATLFASRRVF-GYVFSNEKQVVDYVTTMAPLVCLSVIMDSLQGVFSG 399 (399)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~i-~~lf~~d~~~~~~~~~~l~~~~~~~~~~~~~~v~~G 399 (399)
|+...........+.. . ..+..--+++++ -.+++-||++.+.+...+.++....++++...+.+|
T Consensus 83 --rr~~vl~~~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qG 150 (345)
T PF07260_consen 83 --RRKAVLCMAVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQG 150 (345)
T ss_pred --hHHHHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhh
Confidence 2222222222222221 1 111122244443 357889999999999999999999999999888776
No 43
>COG4267 Predicted membrane protein [Function unknown]
Probab=97.13 E-value=0.2 Score=45.52 Aligned_cols=264 Identities=10% Similarity=0.067 Sum_probs=143.5
Q ss_pred HHHHHHHHHhHHHHHHhhhCccchhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCChhHHHHHHHHHHHHHhHH
Q 015819 86 FSVLLGMASALETLCGQAYGAQQYQRIGTQTYTAIFCLFLVCFPLSFLWIYAGKLLVLIGQDPQISHEVGKFMIWLLPAL 165 (399)
Q Consensus 86 ~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~ 165 (399)
..+..|+....++++|...=++|.+++..-+.-...+....+..++.+ .-...++... .|=...+...
T Consensus 74 ~IiTgg~q~iiTRfiSD~lF~k~~~kIlpsy~Gvi~lv~~~a~~ig~~-------vf~~~~~~si-----~yk~l~~~~F 141 (467)
T COG4267 74 QIITGGFQLIITRFISDCLFEKKQRKILPSYIGVILLVTLVAGVIGLI-------VFFVNNQYSI-----VYKILACALF 141 (467)
T ss_pred HHHhhhHHHHHHHHHHHHHHHHHHHHHhHhHHHHHHHHHHHHHHHHHH-------hhhhcCchhH-----HHHHHHHHHH
Confidence 456778888889999998888888877665554444444433333321 1111222211 1212233344
Q ss_pred HHHHHHHHHHHHHHHcCchhHHHHHHHHHHHhHHHHHHHHhhhccCccchhHHHHHHHHHHHHHHHHHHHHhcccccccC
Q 015819 166 FAYATMQPLIRYFQSQSLIIPMFLSSCAALCLHIPICWSLVYKSGLGNLGGALAIGISNWLNVTFLAIYMKFSTACAESR 245 (399)
Q Consensus 166 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~~~a~~i~~~~~~~~~~~~~~~~~~~~~~~ 245 (399)
...+..-.....+.+.++.+.....-..+.++..++..++-. .+++|..++..++..+.......+..+.-+- +.+
T Consensus 142 V~m~~~Wi~~iFlS~lK~y~~iv~sF~iG~~~sv~La~~~~~---~~ie~lLL~~~IGi~~i~~l~~~~Ilr~fk~-~~~ 217 (467)
T COG4267 142 VGMSLVWILMIFLSGLKKYKLIVLSFFIGYVVSVLLARLFLK---SPIEGLLLTLDIGIFIILFLLNFYILRYFKS-SRR 217 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---hHHHHHHHHHHHhHHHHHHHHHHHHHHhccc-ccc
Confidence 445555566667778888888888888888888888877654 4899999999999988888777776654211 111
Q ss_pred CCCChHHHhcHHHHHHHHhHHHHHHHHHHHHHHHHHHHHhcCCChhHHHH-------HHHHHHHHHHHHHHHHH-----H
Q 015819 246 VPISMELFQGIGEFFHFAIPSAVMICLEWWSFELLILMSGLLPNPQLETS-------VLSVCLNTIQTLYAIPY-----G 313 (399)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a-------~~~i~~~i~~~~~~~~~-----~ 313 (399)
..+.. .+..+. -....+..+..+.+-++++++.=.-+++. +++ -|-+..-.......|.. .
T Consensus 218 i~FdF--L~~~~~----y~SLllIg~FY~lgiwid~FifW~~~~~~-~Iag~~~~S~lYDvpiF~ayl~~iPs~vvF~i~ 290 (467)
T COG4267 218 IGFDF--LLYRRK----YPSLLLIGFFYNLGIWIDNFIFWKVPTGI-EIAGPFFASPLYDVPIFYAYLFIIPSMVVFLIS 290 (467)
T ss_pred cceeh--hhhhhc----chHHHHHHHHHHhHhhhhheeeEecCCCC-EeecceecchhhhHHHHHHHHHhcchhheeeee
Confidence 11111 111111 11223333444455555554332222111 111 13333333333333321 2
Q ss_pred HHHHHHHHH----HHHhcCCC-------hHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhccccCchh
Q 015819 314 LGAAVSTRV----SNELGAGN-------VQKARVAVYAVIFMAVTETIVVSATLFASRRVFGYVFSNEKQ 372 (399)
Q Consensus 314 i~~a~~~~~----~~~~g~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~ 372 (399)
+-+...+.- .+--|.+. .++.....|..+.-..-+-...++.++.+++.+..+|+-|+.
T Consensus 291 lET~F~~~Yk~~y~~I~~g~tl~~I~~~~~kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~~ 360 (467)
T COG4267 291 LETDFQENYKEYYQAIRGGGTLREIENNLKKMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSEY 360 (467)
T ss_pred eeehHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHHH
Confidence 222233322 11112222 233444555555556666678888899999999999987664
No 44
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=96.85 E-value=0.01 Score=51.91 Aligned_cols=67 Identities=19% Similarity=0.231 Sum_probs=60.9
Q ss_pred HHHHhhHHHHHHHHHHHHHHHHHHHHHhc-cChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhh
Q 015819 37 KQGYIAAPMVAVTLSQYLLQVVSMMMVGH-LGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQA 103 (399)
Q Consensus 37 ~i~~~~~p~~~~~~~~~~~~~i~~~~i~~-~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~ 103 (399)
+.++.+.|..++++.......+|..+++. +|++++|.|+.+.++.+.+...+..++++...|..+|.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~~~g~y~~a~~l~~~~~~~~~~~i~~~~~p~lar~ 251 (251)
T PF13440_consen 184 RLLKYGLPFSLSSLLSWLLSQIDRLLIGYFLGPEAVGIYSVAQRLASLPASLLSSAISSVFFPKLARM 251 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCC
Confidence 47999999999999999999999999999 69999999999999999872288999999999988873
No 45
>COG4267 Predicted membrane protein [Function unknown]
Probab=91.15 E-value=11 Score=34.70 Aligned_cols=95 Identities=11% Similarity=0.050 Sum_probs=60.5
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHH
Q 015819 110 QRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMF 188 (399)
Q Consensus 110 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 188 (399)
++.....++.+.-..-+-.+.++. +..++.+..+++-++-. .+.+++-.++..+......+..+.--.++.+..+
T Consensus 320 ~kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~~~----l~lF~vd~lg~s~~i~f~~ll~i~lyfd~r~i~l 395 (467)
T COG4267 320 KKMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSEYY----LDLFYVDVLGVSCQIVFMSLLNIFLYFDYRRIAL 395 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhh
Confidence 344444555554455555566666 88899999999876532 2334444555555444444444444557788888
Q ss_pred HHHHHHHHhHHHHHHHHhhh
Q 015819 189 LSSCAALCLHIPICWSLVYK 208 (399)
Q Consensus 189 ~~~~~~~~~~i~l~~~li~~ 208 (399)
.....-.+.|-.+++++...
T Consensus 396 ~~t~~fli~N~ilT~i~l~l 415 (467)
T COG4267 396 ELTALFLISNGILTFIFLEL 415 (467)
T ss_pred hhhhHHHHHhHHHHHHHHHh
Confidence 87888888999999887653
No 46
>KOG0569 consensus Permease of the major facilitator superfamily [Carbohydrate transport and metabolism]
Probab=75.39 E-value=84 Score=30.63 Aligned_cols=33 Identities=3% Similarity=-0.018 Sum_probs=22.1
Q ss_pred CchhHHHHHHHHHHHhHHHHHHHHhhhccCccchh
Q 015819 182 SLIIPMFLSSCAALCLHIPICWSLVYKSGLGNLGG 216 (399)
Q Consensus 182 ~~~~~~~~~~~~~~~~~i~l~~~li~~~~~g~~G~ 216 (399)
.|...........++.|.+....+... ....|.
T Consensus 401 ~R~aa~s~~~~~~w~~~fiv~~~fp~l--~~~~g~ 433 (485)
T KOG0569|consen 401 ARSAAQSVATAVNWLSNFIVGFAFPPL--QNVIGP 433 (485)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHHHHH--HHHhcc
Confidence 356666777777888888877776644 345554
No 47
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=75.03 E-value=23 Score=24.91 Aligned_cols=38 Identities=21% Similarity=0.204 Sum_probs=28.9
Q ss_pred HHHHHHHHHHHHHhcCCChHHHHHHHHHHHHHHHHHHH
Q 015819 313 GLGAAVSTRVSNELGAGNVQKARVAVYAVIFMAVTETI 350 (399)
Q Consensus 313 ~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 350 (399)
-++-..+..+...+.+||++++++..+++.+++.+-.+
T Consensus 35 i~Ai~~s~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~ 72 (82)
T PF04505_consen 35 IVAIVYSSKVRSRYAAGDYEGARRASRKAKKWSIIAII 72 (82)
T ss_pred HHHheechhhHHHHHCCCHHHHHHHHHHhHHHHHHHHH
Confidence 33444566778888899999999999999988864433
No 48
>PF14184 YrvL: Regulatory protein YrvL
Probab=57.14 E-value=91 Score=24.26 Aligned_cols=105 Identities=11% Similarity=0.142 Sum_probs=59.7
Q ss_pred HHHHHHHHHHHHHHHHHHHhHHHHHHHcCCC-hhHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHHcCchhHHHHHHHHHH
Q 015819 117 YTAIFCLFLVCFPLSFLWIYAGKLLVLIGQD-PQISHEVGKFMIWLLPALFAYATMQPLIRYFQSQSLIIPMFLSSCAAL 195 (399)
Q Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 195 (399)
.......+...++.+...+...-+.+++|-+ +.......-.+....++.|+......+...+.-.+.++.... ....
T Consensus 5 ~~~i~~~l~~~~v~a~~ff~~~gif~L~Gi~Y~S~~~llLF~li~~~lg~~~e~~~k~l~~~l~~~~~~~~~~~--~l~~ 82 (132)
T PF14184_consen 5 IIFIIIALLLIIVFAIYFFVMVGIFHLLGIEYESVGSLLLFFLIIFVLGLPFELFEKVLLKALLFLRMSRRLFI--LLAF 82 (132)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhCcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCchHHHH--HHHH
Confidence 3344444555555555566667777887654 222233333344556777888887777776665533333332 4566
Q ss_pred HhHHHHHHHHhhhccCccchhHHHHHHH
Q 015819 196 CLHIPICWSLVYKSGLGNLGGALAIGIS 223 (399)
Q Consensus 196 ~~~i~l~~~li~~~~~g~~G~~~a~~i~ 223 (399)
.+...+++..++.-+.=+.++.+.+..-
T Consensus 83 ~id~~~t~~~i~~aD~~m~sI~is~~~e 110 (132)
T PF14184_consen 83 IIDFLFTWITIYTADELMESISISTLSE 110 (132)
T ss_pred HHHHHHHHHHHHHHHHHhcceeeCcHHH
Confidence 7777888877776443355555444433
No 49
>PF02487 CLN3: CLN3 protein; InterPro: IPR003492 Batten's disease, the juvenile variant of neuronal ceroid lipofuscionosis (NCL), is a recessively inherited disorder affecting children of 5-10 years of age. The disease is characterised by progressive loss of vision, seizures and psychomotor disturbances. Biochemically, the disease is characterised by lysosomal accumulation of hydrophobic material, mainly ATP synthase subunit C, largely in the brain but also in other tissues. The disease is fatal within a decade []. Mutations in the CLN3 gene are believed to cause Batten's disease []. The CLN3 gene, with a predicted 438-residue product, maps to chromosome p16p12.1. The gene contains at least 15 exons spanning 15kb and is highly conserved in mammals []. A 1.02kb deletion in the CLN3 gene, occurring in either one or both alleles, is found in 85% of Batten disease chromosomes causing a frameshift generating a predicted translated product of 181 amino acid residues [, ]. 22 other mutations, including deletions, insertions and point mutations, have been reported. It has been suggested that such mutations result in severely truncated CLN3 proteins, or affect its structure/conformation [, ]. CLN3 proteins, which are believed to associate in complexes, are heavily glycosylated lysosomal membrane proteins [], containing complex Asn-linked oligosaccharides []. Extensive glycosylation is important for the stability of these lysosomal proteins in the highly hydrolytic lysosomal lumen. Lysosomal sequestration of active lysosomal enzymes, transport of degraded molecules from the lysosomes, and fusion and fission between lysosomes and other organelles. The CLN3 protein is a 43kDa, highly hydrophobic, multi-transmembrane (TM), phosphorylated protein []. Hydrophobicity analysis predicts 6-9 TM segments, suggesting that CLN3 is a TM protein that may function as a chaperone or signal transducer. The majority of putative phosphorylation sites are found in the N-terminal domain, encompassing 150 residues []. Phosphorylation is believed to be important for membrane compartment interaction, in the formation of functional complexes, and in regulation and interactions with other proteins []. CLN3 contains several motifs that may undergo lipid post-translational modifications (PTMs). PTMs contribute to targeting and anchoring of modified proteins to distinct biological membranes []. There are three general classes of lipid modification: N-terminal myristoylation, C-terminal prenylation, and palmitoylation of cysteine residues. Such modifications are believed to be a common form of PTM occurring in 0.5% of all cellular proteins, including brain tissue []. The C terminus of the CLN3 contains various lipid modification sites: C435, target for prenylation; G419, target for myristoylation; and C414, target for palmitoylation []. Prenylation results in protein hydrophobicity, influences interaction with upstream regulatory proteins and downstream effectors, facilitates protein-protein interaction (multisubunit assembly) and promotes anchoring to membrane lipids. The prenylation motif, Cys-A-A-X, is highly conserved within CLN3 protein sequences of different species []. Species with known CLN3 protein homologues include: Homo sapiens, Canis familiaris, Mus musculus, Saccharomyces cerevisiae and Drosophila melanogaster.; GO: 0016020 membrane
Probab=38.82 E-value=73 Score=30.18 Aligned_cols=30 Identities=13% Similarity=0.273 Sum_probs=21.7
Q ss_pred cchhhhHHHHHHHHHhhHHHHHHHHHHHHH
Q 015819 26 TTWGVLSGEVKKQGYIAAPMVAVTLSQYLL 55 (399)
Q Consensus 26 ~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~ 55 (399)
.+++...+..|.++++.+|..+.-+.+...
T Consensus 233 ~~~~~k~~~~k~Ll~ymiPL~lVY~aEY~I 262 (402)
T PF02487_consen 233 LSFKEKLKRLKPLLWYMIPLFLVYFAEYFI 262 (402)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 344444667788888999998888877655
No 50
>PF03904 DUF334: Domain of unknown function (DUF334); InterPro: IPR005602 This is a family of proteins found in Staphylococcus aureus plasmid with no characterised function.
Probab=34.97 E-value=2.1e+02 Score=24.48 Aligned_cols=38 Identities=13% Similarity=0.341 Sum_probs=19.8
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcC
Q 015819 108 QYQRIGTQTYTAIFCLFLVCFPLSFLWIYAGKLLVLIG 145 (399)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 145 (399)
+++...+.+..++...+++.++++++..+..++..+++
T Consensus 142 ~y~k~~k~~~~gi~aml~Vf~LF~lvmt~g~d~m~fl~ 179 (230)
T PF03904_consen 142 KYQKRQKSMYKGIGAMLFVFMLFALVMTIGSDFMDFLH 179 (230)
T ss_pred HHHHHHHHHHHhHHHHHHHHHHHHHHHHhcccchhhhh
Confidence 44444555555554444444444455555556666665
No 51
>TIGR00383 corA magnesium Mg(2+) and cobalt Co(2+) transport protein (corA). The article in Microb Comp Genomics 1998;3(3):151-69 (Medline:98448512) discusses this family and suggests that some members may have functions other than Mg2+ transport.
Probab=32.49 E-value=1.8e+02 Score=26.44 Aligned_cols=57 Identities=12% Similarity=-0.113 Sum_probs=25.0
Q ss_pred hhHHHHHHHHHHHhHHHHHHHHhhhccCc------cchhHHHHHHHHHHHHHHHHHHHHhccc
Q 015819 184 IIPMFLSSCAALCLHIPICWSLVYKSGLG------NLGGALAIGISNWLNVTFLAIYMKFSTA 240 (399)
Q Consensus 184 ~~~~~~~~~~~~~~~i~l~~~li~~~~~g------~~G~~~a~~i~~~~~~~~~~~~~~~~~~ 240 (399)
.+..-..++++.++-.+-.+.-+++.+++ ....++......++..+..+++++|++|
T Consensus 255 N~~mk~LTvvt~IflP~t~IaGiyGMNf~~mP~l~~~~gy~~~l~~m~~i~~~~~~~fkrk~W 317 (318)
T TIGR00383 255 NEIMKILTVVSTIFIPLTFIAGIYGMNFKFMPELNWKYGYPAVLIVMAVIALGPLIYFRRKGW 317 (318)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhCCcccCccccchhHHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 44444445555555444334334443322 1112333333334444555666766654
No 52
>PF07782 DC_STAMP: DC-STAMP-like protein; InterPro: IPR012858 This group of sequences is similar to a region of the dendritic cell-specific transmembrane protein (DC-STAMP, Q9H295 from SWISSPROT). This is thought to be a novel receptor protein that shares no identity with other multimembrane-spanning proteins []. It is thought to have seven putative transmembrane regions [], two of which are found in the region featured in this family. DC-STAMP is also described as having potential N-linked glycosylation sites and a potential phosphorylation site for PKC [], but these are not conserved. ; GO: 0016021 integral to membrane
Probab=30.99 E-value=1e+02 Score=25.74 Aligned_cols=52 Identities=10% Similarity=-0.012 Sum_probs=38.7
Q ss_pred ccccCCcccCCCCCcchhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHH
Q 015819 12 ESLLIPKESLSSSSTTWGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMV 63 (399)
Q Consensus 12 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i 63 (399)
-|+..+++.+.-+..+++..+++.+++.+-.++.++..+...+...+|..+-
T Consensus 26 LPL~~~E~~~yi~~~s~~lt~~E~~~~~~~~~~l~~~~~~~~~~~~~D~~ly 77 (191)
T PF07782_consen 26 LPLRKKERKKYIDPTSLRLTRKERKRLLRSLLFLLLHLLQWLVIIALDYLLY 77 (191)
T ss_pred CCCCccccccEeccCcCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3444444444344556666688999999999999999999999999988764
No 53
>PRK11085 magnesium/nickel/cobalt transporter CorA; Provisional
Probab=30.66 E-value=3.5e+02 Score=24.72 Aligned_cols=58 Identities=14% Similarity=-0.045 Sum_probs=24.6
Q ss_pred chhHHHHHHHHHHHhHHHHHHHHhhhccCc-cch-----hHHHHHHHHHHHHHHHHHHHHhccc
Q 015819 183 LIIPMFLSSCAALCLHIPICWSLVYKSGLG-NLG-----GALAIGISNWLNVTFLAIYMKFSTA 240 (399)
Q Consensus 183 ~~~~~~~~~~~~~~~~i~l~~~li~~~~~g-~~G-----~~~a~~i~~~~~~~~~~~~~~~~~~ 240 (399)
.....-+.++++.++..+-.+.-+++.++. +-+ ..+......++.++..+++++|++|
T Consensus 252 ~N~~mk~lTv~s~if~pptliagiyGMNf~~mP~~~~~~g~~~~l~~~~~~~~~~~~~f~rk~W 315 (316)
T PRK11085 252 QNRIIKIFSVVSVVFLPPTLVASSYGMNFEFMPELKWSFGYPGAIILMILAGLAPYLYFKRKNW 315 (316)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCCCCcHHHHHHHHHHHHHHHHHHHHHHHccc
Confidence 344444445555555444444444443332 111 1222223333334444556666544
No 54
>KOG0637 consensus Sucrose transporter and related proteins [Carbohydrate transport and metabolism]
Probab=27.56 E-value=2.2e+02 Score=27.58 Aligned_cols=103 Identities=14% Similarity=0.057 Sum_probs=54.8
Q ss_pred HHHHHhhHHHHHHHHHHHHHHHHHHHHHhccChhHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHhhhCccchhHHHHH
Q 015819 36 KKQGYIAAPMVAVTLSQYLLQVVSMMMVGHLGQLALSSTAMAISLASVTGFSVLLGMASALETLCGQAYGAQQYQRIGTQ 115 (399)
Q Consensus 36 ~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~g~~~~~~~~~a~~i~~~~~~~~~~gl~~a~~~~~s~~~g~~~~~~~~~~ 115 (399)
++++..+.-.+--++....-...-+..+-.+ ++--.+.++. ....--.+.-++|.++..- |+-+.|--
T Consensus 32 ~~li~v~~ia~Gvqf~wA~elsy~tPyl~~l--------Gvphk~~S~i-w~~gPi~G~~vQP~vG~~S---Drc~sr~G 99 (498)
T KOG0637|consen 32 RKLISVASIAAGVQFGWALELSYLTPYLQSL--------GVPHKWSSII-WLCGPLSGLLVQPLVGSAS---DRCTSRYG 99 (498)
T ss_pred HHHHHHHHHHHHHHHHHHHHhccccHHHHHc--------CCCccccccc-ccccccccceecccccccc---cccccccc
Confidence 6666666666555555544433333333323 2223444443 3333334455567766642 33333322
Q ss_pred HHHHHHHHHHHHHHHHHH-HHhHHHHHHHcCCChhH
Q 015819 116 TYTAIFCLFLVCFPLSFL-WIYAGKLLVLIGQDPQI 150 (399)
Q Consensus 116 ~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~~~~~~ 150 (399)
-++-+.......+.+.+. +.+++.+-..++++++.
T Consensus 100 RRRPfI~~~s~~i~~~l~Lig~aaDig~~lgd~~~~ 135 (498)
T KOG0637|consen 100 RRRPFILAGSLLIAVSLFLIGYAADIGLLLGDNERK 135 (498)
T ss_pred cccchHHHhhHHHHHHHhhhhhHhhhhHHhcCCccc
Confidence 334445555555666666 88899999999887654
No 55
>PRK10739 putative antibiotic transporter; Provisional
Probab=26.42 E-value=3.9e+02 Score=22.44 Aligned_cols=59 Identities=8% Similarity=0.053 Sum_probs=37.3
Q ss_pred HHHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHH
Q 015819 319 STRVSNELGAGNVQKARVAVYAVIFMAVTETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMA 381 (399)
Q Consensus 319 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l 381 (399)
.|..-...+..++++-|+..++...++. .+.++..++.+.+.++|+-+-+..+.+-..+
T Consensus 21 ipiflslt~~~~~~~r~~ia~~a~~~a~----~ill~f~~~G~~iL~~fGIsl~afrIAGGil 79 (197)
T PRK10739 21 LPIFMSVLKHLEPKRRRAIMIRELLIAL----LVMLVFLFAGEKILAFLNLRTETVSISGGII 79 (197)
T ss_pred HHHHHHHhCCCCHHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHhCCCHHHHHHHHHHH
Confidence 3444444455566666667766654444 5555778889999999987765555554443
No 56
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=24.28 E-value=2.6e+02 Score=19.60 Aligned_cols=32 Identities=13% Similarity=0.123 Sum_probs=23.4
Q ss_pred HHHHHHhhhCccchhHHHHHHHHHHHHHHHHH
Q 015819 96 LETLCGQAYGAQQYQRIGTQTYTAIFCLFLVC 127 (399)
Q Consensus 96 ~~~~~s~~~g~~~~~~~~~~~~~~~~~~~~~~ 127 (399)
.+..+-+.+.++|++++++..+++..++.+..
T Consensus 40 ~s~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~ 71 (82)
T PF04505_consen 40 YSSKVRSRYAAGDYEGARRASRKAKKWSIIAI 71 (82)
T ss_pred echhhHHHHHCCCHHHHHHHHHHhHHHHHHHH
Confidence 33555667778999999999988877765443
No 57
>COG2211 MelB Na+/melibiose symporter and related transporters [Carbohydrate transport and metabolism]
Probab=23.49 E-value=7e+02 Score=24.32 Aligned_cols=32 Identities=6% Similarity=-0.020 Sum_probs=23.5
Q ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhc
Q 015819 34 EVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGH 65 (399)
Q Consensus 34 ~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~ 65 (399)
.+||-+.++.+=+.+++.......--..+...
T Consensus 10 s~~eki~Yg~gd~~~~~~~~~~~~yLl~fYTd 41 (467)
T COG2211 10 SLKEKIGYGLGDFASNFAFGIVVLYLLFFYTD 41 (467)
T ss_pred cHHHHHhhcchhhHHHHHHHHHHHHHHHHHhc
Confidence 46888899999888887777666665555555
No 58
>PF06609 TRI12: Fungal trichothecene efflux pump (TRI12); InterPro: IPR010573 This family consists of several fungal specific trichothecene efflux pump proteins. Many of the genes involved in trichothecene toxin biosynthesis in Fusarium sporotrichioides are present within a gene cluster. It has been suggested that TRI12 may play a role in F. sporotrichioides self-protection against trichothecenes [].
Probab=22.46 E-value=8.2e+02 Score=24.77 Aligned_cols=76 Identities=13% Similarity=0.098 Sum_probs=37.5
Q ss_pred CCcccccccccccCCcccCCCCCcchhhhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHhcc-ChhHHHHHHHHHHHH
Q 015819 3 GNETEKNMEESLLIPKESLSSSSTTWGVLSGEVKKQGYIAAPMVAVTLSQYLLQVVSMMMVGHL-GQLALSSTAMAISLA 81 (399)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~p~~~~~~~~~~~~~i~~~~i~~~-g~~~~~~~~~a~~i~ 81 (399)
++|+|+.+++.+..++.++++. ..+. ++..-.+...+.-..-..+...+...+...+...+ +++..+.++.++.+.
T Consensus 14 ~~~~~~~~~~a~~~~~~~~p~g--~~~s-~~~i~~~~~~~~~~~~~~~~~~~~a~~l~~I~~diG~~~~~~w~~~~~~l~ 90 (599)
T PF06609_consen 14 SQPDDRIRAEALGTEADELPDG--YYRS-PRFIASFAAFSLAVIAAYFVLVLPASILPYINADIGGSDNWSWFSTAWTLA 90 (599)
T ss_pred CCcchhHHHHHhcCchhhCCCC--ceeC-HHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHhcCCCccchHHHHHHHHH
Confidence 3455555566665544443222 2211 33444444455555545555555555555555667 445555555554443
No 59
>PF05975 EcsB: Bacterial ABC transporter protein EcsB; InterPro: IPR010288 ABC transporters belong to the ATP-Binding Cassette (ABC) superfamily, which uses the hydrolysis of ATP to energise diverse biological systems. ABC transporters minimally consist of two conserved regions: a highly conserved ATP binding cassette (ABC) and a less conserved transmembrane domain (TMD). These can be found on the same protein or on two different ones. Most ABC transporters function as a dimer and therefore are constituted of four domains, two ABC modules and two TMDs. ABC transporters are involved in the export or import of a wide variety of substrates ranging from small ions to macromolecules. The major function of ABC import systems is to provide essential nutrients to bacteria. They are found only in prokaryotes and their four constitutive domains are usually encoded by independent polypeptides (two ABC proteins and two TMD proteins). Prokaryotic importers require additional extracytoplasmic binding proteins (one or more per systems) for function. In contrast, export systems are involved in the extrusion of noxious substances, the export of extracellular toxins and the targeting of membrane components. They are found in all living organisms and in general the TMD is fused to the ABC module in a variety of combinations. Some eukaryotic exporters encode the four domains on the same polypeptide chain []. The ABC module (approximately two hundred amino acid residues) is known to bind and hydrolyse ATP, thereby coupling transport to ATP hydrolysis in a large number of biological processes. The cassette is duplicated in several subfamilies. Its primary sequence is highly conserved, displaying a typical phosphate-binding loop: Walker A, and a magnesium binding site: Walker B. Besides these two regions, three other conserved motifs are present in the ABC cassette: the switch region which contains a histidine loop, postulated to polarise the attaching water molecule for hydrolysis, the signature conserved motif (LSGGQ) specific to the ABC transporter, and the Q-motif (between Walker A and the signature), which interacts with the gamma phosphate through a water bond. The Walker A, Walker B, Q-loop and switch region form the nucleotide binding site [, , ]. The 3D structure of a monomeric ABC module adopts a stubby L-shape with two distinct arms. ArmI (mainly beta-strand) contains Walker A and Walker B. The important residues for ATP hydrolysis and/or binding are located in the P-loop. The ATP-binding pocket is located at the extremity of armI. The perpendicular armII contains mostly the alpha helical subdomain with the signature motif. It only seems to be required for structural integrity of the ABC module. ArmII is in direct contact with the TMD. The hinge between armI and armII contains both the histidine loop and the Q-loop, making contact with the gamma phosphate of the ATP molecule. ATP hydrolysis leads to a conformational change that could facilitate ADP release. In the dimer the two ABC cassettes contact each other through hydrophobic interactions at the antiparallel beta-sheet of armI by a two-fold axis [, , , , , ]. The ATP-Binding Cassette (ABC) superfamily forms one of the largest of all protein families with a diversity of physiological functions []. Several studies have shown that there is a correlation between the functional characterisation and the phylogenetic classification of the ABC cassette [, ]. More than 50 subfamilies have been described based on a phylogenetic and functional classification [, , ]; (for further information see http://www.tcdb.org/tcdb/index.php?tc=3.A.1). This family consists of several bacterial ABC transporter proteins which are homologous to the EcsB protein of Bacillus subtilis. EcsB is thought to encode a hydrophobic protein with six membrane-spanning helices in a pattern found in other hydrophobic components of ABC transporters [].
Probab=22.38 E-value=6.6e+02 Score=23.63 Aligned_cols=40 Identities=15% Similarity=0.221 Sum_probs=29.4
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHHH-HHhHHHHHH-HcCCC
Q 015819 108 QYQRIGTQTYTAIFCLFLVCFPLSFL-WIYAGKLLV-LIGQD 147 (399)
Q Consensus 108 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~-~~~~~ 147 (399)
++++.+++.+.+...+.....+..++ ....-|+.. ..+.+
T Consensus 89 ~e~~~~~y~~~a~~yS~~~~~~~~~~~~~ll~Pl~~~~~~~~ 130 (386)
T PF05975_consen 89 KESEMKQYFKRALRYSFVLQLLIQLLVFLLLLPLLMQVYGFS 130 (386)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 35679999999999999888887766 666666665 44433
No 60
>PF01914 MarC: MarC family integral membrane protein; InterPro: IPR002771 Members of this family are integral membrane proteins that includes the antibiotic resistance protein MarC. These proteins may be transporters. ; GO: 0016021 integral to membrane
Probab=21.61 E-value=4.9e+02 Score=21.91 Aligned_cols=58 Identities=5% Similarity=-0.054 Sum_probs=36.0
Q ss_pred HHHHHHhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhhccccCchhHHHHHHHHH
Q 015819 320 TRVSNELGAGNVQKARVAVYAVIFMAVTETIVVSATLFASRRVFGYVFSNEKQVVDYVTTMA 381 (399)
Q Consensus 320 ~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lf~~d~~~~~~~~~~l 381 (399)
|..-..-+..+.++-|+..++....+ ..+..++.++++.+.++|+-+-+..+.+-.++
T Consensus 22 p~f~~lt~~~~~~~r~~ia~~a~~~a----~~ill~f~~~G~~iL~~fgIsl~af~IaGGii 79 (203)
T PF01914_consen 22 PIFLSLTKGMSPKERRRIARRASIIA----FIILLIFAFFGQLILNFFGISLPAFRIAGGII 79 (203)
T ss_pred HHHHHHhCCCCHHHHHHHHHHHHHHH----HHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHH
Confidence 33444444455556666666655444 46667778889999999986655555444443
Done!